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ABSTRACT
Background
Although intrapartum hypoxia-ischaemia is an important cause of death and permanent 
brain injury, current available methods for the detection of damaging fetal hypoxia are 
unsatisfactory and unreliable. Electronic fetal heart rate monitoring (EFM) is considered 
to be the “gold standard” for intrapartum fetal surveillance. However, monitoring of the 
fetal heart rate provides an indirect measure of fetal hypoxia and provides little 
indication of the adequacy of cerebral perfusion. Consequently, EFM has a false 
positive rate of 99.8% in the detection of fetuses that subsequently develop cerebral 
palsy. A direct consequence of the poor specificity of fetal heart rate monitoring is a 
high rate of unnecessary Caesarean sections with associated fetal and maternal 
morbidity.
Most fetuses subjected to intrapartum hypoxia will be protected from brain injury by 
appropriate changes in cardiovascular distribution. It is the aim of fetal surveillance to 
detect the minority of fetuses in whom this response is absent and who are at risk of 
permanent brain injury.
Intrapartum fetal pulse oximetry is a promising new method of fetal surveillance, 
enabling measurement of fetal arteriolar saturation but the technique provides no direct 
information on cerebral oxygen delivery.
Intrapartum measurement of fetal cerebral saturation and changes in blood volume has 
been described using conventional near infrared spectroscopy (NIRS). However, the 
clinical relevance of these values may be limited. This is because these values are 
derived from changes in the concentrations of oxyhaemoglobin (HbCh) and 
deoxyhaemoglobin (Hb) from an arbitrary baseline. Furthermore, the contribution of 
artefact to NIRS measurements of Hb and HbC>2 changes, arising from possible changes 
in the geometry of the NIRS fetal probes during uterine contractions, has not been 
clearly defined.
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Using novel methods of collection and analysis of NIRS data, the technique of Intensity 
Modulated Optical Spectroscopy (IMOS) has the unique potential to provide direct 
information on fetal cerebral oxygenation and perfusion during labour from measured 
absolute values of fetal cerebral Hb02 and Hb.
Furthermore, the technique of IMOS has the potential to provide more information on 
the contribution of probe movement during uterine contractions to conventional NIRS 
data.
Aims
The aims of this project were therefore to use this new technique of intensity modulated 
optical spectroscopy to (a) provide the first measurements of absolute cerebral blood 
volume and cerebral saturation in healthy normoxic human fetuses during labour and 
(b) to compare these values with those calculated from fetuses that develop hypoxia- 
ischaemia during labour and (c) to assess the contribution of probe movement during 
uterine contractions.
Methods
After assessing and optimising the technical performance of a specially designed and 
constructed intensity modulated optical spectrometer, a specially designed optical probe 
was placed against the scalp of 29 fetuses after rupture of amniotic membranes during 
labour and connected to the spectrometer.
Results
Of these 29 fetuses, data were collected from 18 fetuses during the first and second 
stage of labour through to delivery. Of these 18, data was suitable for analysis in 10 of 
these fetuses. In these 10 fetuses, a mean (+/-1 S.D.) value of cerebral saturation of 59 
+/-12 % and a mean absolute cerebral blood volume of 2.8 +/-1.0mls/100g over 3 
uterine contractions were derived from the mean concentrations of Hb and Hb02 of 30 
+/-18 and 46 +/-21 pmol/1, respectively.
Concentration changes rather than artefact appeared to dominate the NIR signal in the 
calculation of these values.
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Conclusion
This work has provided the first measurements of absolute values of fetal cerebral 
oxygenation and of cerebral perfusion, whilst the contribution of artefact to the data, 
certainly in the healthy fetus, appears to be negligible. However, despite these advances 
in near infrared technology and knowledge of intrapartum fetal cerebral 
haemodynamics, the number of fetuses studied with near infrared spectroscopy, in 
particular IMOS, remains small. In order for IMOS to be subjected to larger studies to 
assess it’s usefulness as a realistic adjunct to fetal heart rate monitoring, advances in the 
technology are still required.
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CHAPTER 1
INTRODUCTION
Despite striking advances in obstetric and neonatal care, encephalopathy induced by 
hypoxia-ischaemia of the fetus and newborn infant continues to be an important 
problem in society. Cerebral palsy develops in approximately 2-3 out of 1000 live births 
during the first years of life (Bakketeig 1999), and its association with the intrapartum 
period has contributed to the speciality of obstetrics and gynaecology having the highest 
proportion of medical litigation and damages paid for hospital claims. Known liabilities 
for brain damaged babies have been valued at between £660 million and £1 billion 
(Symonds 1993) and over a third of obstetric claims notified to the Medical Defence 
Union arise ffom allegations that intrapartum hypoxia resulted in permanent brain 
damage or perinatal death (James 1991).
Thus one of the tasks of the obstetrician is the prevention of any condition which could 
jeopardise the proper functioning and viability of the fetus and its brain. Because of this, 
considerable attention over the last few decades has been devoted to the understanding 
of the neuropathological sequelae of hypoxia-ischaemia during the perinatal period in 
the hope that this will lead to the development of improved diagnostic and predictive 
modalities. Both clinical studies and experiments in laboratory animals have attempted 
to describe the effect of hypoxia-ischaemia on the developing fetal brain and to explain 
the physiological as well as the abnormal fetal and newborn cardiovascular and 
respiratory responses, which may be relevant to human fetuses during labour.
This chapter explains the background upon which this thesis is based. Firstly, the role of 
hypoxic intrapartum events in the aetiology of brain injury and long term neurological 
handicap is discussed. Current knowledge of the underlying pathophysiology of hypoxic
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fetal brain injury and the fetal response to hypoxia are then reviewed. This provides the 
background to assess a) the clinical outcome measures used to identify those neonates 
thought to be at risk of subsequent long term neurological handicap and b) the 
usefulness of the current available methods to monitor fetuses to detect those at risk of 
cerebral damage during labour.
1.1 FETAL BRAIN INJURY
1.1.1 Intrapartum events and cerebral palsy
Historically, the association of cerebral palsy and intrapartum events has led to much 
controversy, which has continued up to the present day. In 1843 William John Little, a 
London Orthopaedic surgeon published his lectures on Deformities of the Human 
Frame, and described a 'spasmodic tetanus-like rigidity and distortion of the limbs of 
new-born infants' following asphyxia neonatorum, and mechanical injury to the fetus 
immediately before or during parturition. His subsequent thesis concluded that cerebral 
palsy was primarily due to perinatal cerebral injury. Little’s work was supported by 
William Osier in 1888 who first used the term 'cerebral palsy' and stressed its 
association with birth asphyxia in many cases. This view that cerebral palsy necessarily 
followed birth asphyxia or trauma, was subsequently challenged by Sigmund Freud who 
stressed that there was a lack of correlation of clinical findings with either purported 
aetiology or neuropathological findings in the neonate. Within the last decade evidence 
has emerged to challenge the old concept that most cases of cerebral palsy begin in 
labour. Clinical epidemiological studies have indicated that in most cases the events 
leading to cerebral palsy occur in the fetus before the onset of labour, or in the newborn 
after delivery (Blair 1988,1993). A large proportion of cases of cerebral palsy is now 
thought to arise antenatally (Badawi et al 1998). In addition, neonatal causes of cerebral 
palsy which include metabolic abnormalities (Volpe 1995) autoimmune and coagulation 
disorders (Nelson 1998a), infections (Grether 1997) and developmental abnormalities 
(Stanley 1984, Nelson 1986) require exclusion before a case of cerebral palsy could be 
considered to arise from intrapartum events.
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Intrauterine infection
What does seem clear is that in many instances the cause of perinatal brain injury is 
multi-factorial. A source of current speculation is the possible impact of coexisting 
infection and intrapartum hypoxia-ischaemia on the fetal brain. A recent meta-analysis 
found that among full term infants there was a positive correlation between clinical 
chorioamnionitis and cerebral palsy (Wu 2000), while a similar relation exists between 
histologically diagnosed fetal chorioamnionitis and brain injury (Redline 2000). Thus 
combined exposure to infection and intrapartum hypoxia-ischaemia dramatically 
increases the risk of spastic cerebral palsy compared with hypoxia alone (Nelson 
1998b). However, the correlation between severity of maternal disease and neonatal 
outcome is not clear, as many infants bom to mothers with obvious signs of 
chorioamniotis have a normal outcome. Thus the precise relationship between 
antepartum factors, such as inflammatory activation as a result of infection, intrapartum 
hypoxia -ischaemia stress and perinatal brain injury is still unclear (Peebles 2002).
Defining a causal relationship between intrapartum events and cerebral palsy, therefore, 
remains difficult (MacLennan et al 1999). It is now estimated that only 7 to 15% of 
perinatal deaths and cases of neurological impairment in children are the result of 
hypoxic damage occurring during the course of labour and delivery (Blairl988, Badawi 
1998, Nelson 1988, Grant 1989).
Possible antenatal causes of neurological impairment are listed in Table 1.1 (MacLennan 
et al 1999). The presence of any one of these factors greatly reduces the likelihood that 
acute intrapartum hypoxia was the cause, or the sole cause, of any subsequent 
neurological impairment. The absence of any of these factors does not exclude an 
antenatal cause, as much of the evidence can be very difficult to ascertain 
retrospectively.
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Table 1.1 Factors that suggest a cause of cerebral palsy other than acute 
intrapartum hypoxia.
Umbilical arterial base deficit less than 12 mmol/1 or pH greater than 7.00 
Infants with major or multiple congenital or metabolic abnormalities 
Central nervous system or systemic infection
Early imaging evidence of longstanding neurological abnormalities for example, 
ventriculomegaly, porencephaly, multicystic encephalomalacia
Infants with signs of intrauterine growth restriction
Reduced fetal heart rate variability from the onset of labour
Microcephaly at birth (head circumference less than a third of the centile)
Major antenatal placental abruption
Extensive chorioamnionitis
Congenital coagulation disorders in the child
Presence of other major antenatal risk factors for cerebral palsy for example, preterm birth at 
less than 34 weeks' gestation, multiple pregnancy, or autoimmune disease
Presence of major postnatal risk factors for cerebral palsy for example, postnatal encephalitis, 
prolonged hypotension, or hypoxia due to severe respiratory disease
A sibling with cerebral palsy, especially of the same type______________________________
Neonatal brain imaging
Different imaging modalities have been used to define the origin and timing of brain 
lesions in term infants with neonatal encephalopathy. Ultrasound, because of its 
portability and ease of performing serial evaluations, has become the most common 
imaging method used for this purpose. However, resolution is limited to lesions greater 
than 5-8mm, and the peripheral field of view is limited. Computerised tomography 
likewise has limited ability to detect small lesions and to differentiate the grey-white 
matter interface (Barkowitz 1997). Magnetic resonance imaging has far superior 
resolution and currently it is being used more frequently to assess brain structure 
(Robertson and Wyatt 2004). In the most recent study using MRI to assess the timing of 
brain injury, Cowan (2003) suggested that events in the immediate perinatal period are
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most important in neonatal brain injury. Thus, brain images showed evidence of an 
acute insult without established injury or atrophy in 197 (80%) of infants with neonatal 
encephalopathy and evidence of perinatal asphyxia (see table 1.1a). Only 2 infants 
(<1%) had MRI evidence of established injury. Of those infants without other evidence 
of encephalopathy, but who presented with seizures within 3 days of birth, acute focal 
damage was noted in 62(69%) of infants whereas only two (3%) also had MRI evidence 
of antenatal injury.
Table 1.1a MRI abnormalities to define the timing of brain injury (Cowan 2003). 
Signs of an acute perinatal insult
Brain swelling 
Cortical highlighting
Focal or global loss of grey-white matter differentiation
Abnormal signal intensity in the basal ganglia and thalami
Loss of normal signal intensity in the posterior limb of the internal
capsule
Acute and subacute parenchymal, intraventricular or extracerebral 
haemorrhage
Acutely evolving focal infarction in an arterial territory or in a 
parasaggital or watershed distribution
Signs of an antenatal insult
Irregular ventricular dilatation, widening of the interhemispheric 
fissure, enlarged extracerebral space
Established cystic lesions e.g. cystic periventricular leucomalacia 
Focal infarction with atrophy 
Longstanding haemorrhage
Marked asymmetries e.g. in ventricular shape or size 
Developmental abnormalities e.g. abnormal cerebellar development
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1.1.2 PATHOPHYSIOLOGY OF BRAIN INJURY
1.1.2.1 Normal cerebral physiology
The survival of the brain is dependent on a continuous and adequate supply of oxygen 
and nutrients. Maintenance of cerebral perfusion seems to be essential for long-term 
survival (Gunn 1992). Failure of the cerebral circulation results in almost instantaneous 
(less than 2 minutes) neuronal dysfunction with rapid progression to cell death. The 
factors controlling cerebral blood flow are, therefore, of considerable importance. In the 
fetus and newborn, the most common cause of cerebral hypoxia (relative lack of oxygen 
in the tissues) is inadequate oxygen delivery because of lower than normal oxygen 
levels coupled with inadequate cerebral blood flow (ischaemia).
Under normal conditions transport form the maternal circulation is the primary source 
of oxygen for the fetus. Values of the arterial partial pressure of oxygen in the mother 
are higher (aorta: 95mmHg) than that of the fetal umbilical vein (35 mmHg), thus 
allowing a steep gradient to facilitate diffusion of oxygen from mother to fetus. In spite 
of the normally low arterial partial pressure of oxygen, the transport of oxygen to fetal 
tissues appears more than adequate. This is in part due to the increased oxygen carrying 
capacity of the fetal blood, in turn due to the higher haemoglobin concentration, and to 
the higher oxygen affinity, which permits the saturation of fetal blood with oxygen at a 
lower oxygen partial pressure. Thus although the rate of oxygen uptake by the placenta 
is about 50% greater per gram of tissue than that of the fetus, oxygen affinity is higher 
in fetal than in human blood thus ensuring that an adequate supply of oxygen reaches 
the fetal tissues. The fetal carcass (skin, bone, muscle) has the highest (50% of total) 
consumption of absolute oxygen while the brain with the liver and heart make up a 
further 35-40% of total oxygen consumption (Fowden 1995).
Autoregulation
Oxygen delivery to the brain is a product of oxygen content of the blood (derived from 
haemoglobin concentration and saturation) and tissue blood flow (or perfusion,
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measured in ml/min/lOOg). It is commonly stated that the blood flow to the fetal brain 
in the near term infant is approximately lOOml/min/lOOg-brain tissue (Longo 1997). 
Knowledge of the factors controlling cerebral circulation is based on estimates of total 
blood flow to the brain. The perfusion pressure of the blood supplying the brain is the 
difference between the arterial blood pressure and the cerebral venous pressure. The 
mean arterial blood pressure can be altered over a fairly wide range without affecting 
cerebral blood flow.
This phenomenon is called ‘autoregulation’ and is defined as the intrinsic ability of 
cerebral resistance vessels to alter their calibre and maintain a constant blood volume 
and flow in the face of alterations in perfusion pressure (Harper 1990). Cerebral 
arteriolar vasodilatation, resulting in an increase in cerebral blood volume, occurs in 
response to hypotension, hypercapnia (increase in arterial carbon dioxide) and hypoxia. 
A reduction in blood pressure causes at transient reduction in flow and a build up of 
metabolites, such as adenosine and hydrogen ions, which in turn causes vasodilatation 
and a restoration of flow and maintenance of blood volume.
1.1.2.2 Cerebral metabolism
The other nutrients required for fetal growth have important roles in oxidative 
metabolism. Glucose is the main substrate for oxidative metabolism in utero and 
facilitated diffusion of glucose across the placenta occurs. The fetus can also produce 
glucose endogenously by gluconeogenesis in the liver and kidneys, though this usually 
occurs in adverse conditions such as intrauterine growth restriction. Lactate is the 
second most important carbohydrate fuel in the fetus and is mostly derived from 
glucose. The majority of the lactate is consumed by the fetus and utilised in the heart 
and liver. Amino acids are essential for oxidation and their supply is dependent on 
placental metabolism as well as transplacental transport. Lipids are essential for fetal 
growth and play a minor role in oxidative metabolism (Nordstrom 1998).
Under normal conditions, with sufficient oxygenation and perfusion to the fetus, aerobic 
metabolism occurs in which glucose is broken down to pyruvate along the glycolytic
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pathway, within the cytosol. Oxygen is directly consumed at the inner membrane of the 
mitochondrion in the catabolic reaction of NADH to form NAD+ and water. It is this 
reaction that releases large amounts of energy to produce the principle energy source 
within the cell, namely adenosine triphosphate (ATP), via oxidative phosphorylation. 
ATP helps to maintain cellular integrity, as cellular functions require ion gradients, 
which in turn require ATP to function. With sufficient oxygen supply, the cell maintains 
oxidative metabolism and there is a steady state between lactate and pyruvate 
concentrations. If the oxygen supply is less than adequate then the fetus has to engage in 
anaerobic metabolism, ffom which the end products are hydrogen ions and lactate. With 
anaerobic metabolism the lactate/pyruvate ratio increases. Regeneration of NAD+ is 
provided by the oxidation of pyruvate to lactate, concomitantly producing H+ ions 
(lactic acidosis) (see figure 1.1). With depletion in cellular energy, cellular functions 
can not be maintained, as ATP regeneration is stopped (Windle 1944, Dawes 1960).
cytosol
Glucose
2ADP
2ATP
2 NAD
2 H -ATP
2 lactic acid2 Pyruvate
36 ATP ADP mitochondrion
Citric acid cycle
CO
Figure 1.1. Fetal cellular glucose metabolism schematically represented. Glucose is 
broken down along the glycolytic pathway to form pyruvate. Under aerobic conditions 
large amounts of energy (ATP) are produced in the citric acid cycle, whereas anaerobic 
glycolysis renders less energy and lactacidosis.
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Thus three different levels of cellular energy status may occur. The first is aerobic 
metabolism in which there is a sufficient amount of oxygen to produce a large supply of 
energy (ATP). The second level is anaerobic metabolism, in which a lack of oxygen 
forces the cell to produce lactate while generating a limited amount of energy and 
concomitantly producing lactacidosis. Early in this stage energy supply is still 
satisfactory in relation to demand and the cellular energy status is compensated. In the 
third level, regeneration of ATP can no longer be maintained and energy supply to the 
cell can no longer keep up with demands and is thus decompensated. Because the fetal 
brain has a high rate of oxygen consumption and a relative lack of oxygen stores, at 
flow rates below 50ml/min/100g tissue protein synthesis is impaired, while at rates 
below 15 to 20ml/min/100g tissue, adenosine triphosphate (ATP) synthesis is impaired 
and electrical activity fails (Longo 1997). If this low rate persists, cellular 
transmembrane ionic gradients will eventually be lost. These ionic gradients can also be 
lost almost instantaneously if cerebral blood flow is reduced to ~10 ml/min/lOOg brain 
tissue (Hossman 1994). It is at this level that neuronal cell damage is thought to occur 
during a hypoxic-ischaemic event (Heuser 1975, Giffard 1990, Levine 1993).
Therefore it is now well established that there is a primary phase of neuronal loss during 
a hypoxic/ischaemic event likely to be due to deterioration of the cellular steady state 
including acidosis, disturbed ion distributions and altered tissue perfusion. Additionally, 
neuronal cell damage has been shown to occur during a secondary phase of re­
oxygenation and re-perfusion after a hypoxia-ischaemic event (Pulsinelli 1982), which 
can take place hours to days after the event (Bennet 1999). Delayed neuronal and glial 
death occurring in the hours and days after a hypoxic insult by apoptotic and related 
processes are observed following severe injury (Gluckman 2001). The severity of 
cortical neuronal loss may be related to the degree of hypoperfusion in the immediate 
reperfusion period and inversely related to the magnitude of the delayed hyperperfusion 
(Raad 1999). The damaging mechanisms that are thought to be involved in secondary 
neuronal loss are metabolic changes, neurotoxicity and circulatory changes. Oxygen- 
derived free radicals and excitatory amino acids have been implicated (Kjellmar 1989). 
Oxygen-derived free radicals are highly reactive atoms or molecules with an uneven 
number of electrons in their outer-shell. These are generated during normal aerobic
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metabolism but are effectively inactivated by naturally occurring scavenger systems. A 
state of severe metabolic acidosis will cause phospholipid release, providing a substrate 
store for the production of prostaglandins when the brain is subsequently re-perfused as 
the hypoxic insult resolves. The production of prostaglandins has an inevitable by­
product, oxygen radicals. Oxygen free radical production also results ffom the 
breakdown of xanthine and reperfusion of the areas in which xanthine has accumulated 
leads to the formation of uric acid with oxygen radical production again being a by­
product (Nordstrom 1998). The role of oxygen ffee radicals however remains unclear, 
although it is thought that they may disrupt the integrity of blood capillaries, which may 
lead to breakdown of the blood-brain barrier leading to vasogenic oedema.
Similarly, glutamate and other excitatory amino acids have been proposed to have a role 
in the secondary phase of hypoxia-ischaemia neuronal injury (Hagberg 1992). These act 
as neurotransmitters in the brain, with the N-methyl-D-aspartate (NMDA) being the 
most important receptor, and can be released in response to a metabolic acidosis caused 
by profound hypoxia. Stimulation of the NMDA receptor opens up the passage of Na+ 
and Ca2+ ions through the cell membrane, with concomitant intracellular 
hypercalcaemia. In animal models, a high density of NMDA receptors has been found 
in areas of the brain that are vulnerable to hypoxia-ischaemia (Greenmayre 1987). 
During moderately severe isocapnic hypoxia fetal plasma amino acids increase 
significantly (Walker 2000). This may reflect reflex peripheral vasoconstriction in 
skeletal muscle beds and decreased hepatic blood flow, demonstrating the importance of 
skeletal muscle in branched-chain amino acid metabolism. In a fetus that is able to 
successfully buffer any production of lactate and maintain cerebral perfusion, the level 
of amino acids is insufficient to produce neuronal damage. However, as the level of 
lactate rises in response to the hypoxia, the amino acid accumulation threatens neuronal 
integrity. The underlying mechanisms responsible are thought to be acute osmotic 
uptake of sodium and chloride ions and a secondary calcium ion accumulation in the 
neurone (Nordstrom 1998).
It is important to note that there is a constant readjustment of local blood flow to various 
areas to satisfy the metabolic needs of the brain cells. Thus some areas of the brain such
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as the hippocampus, areas of the neocortex, and portions of the caudate nucleus and 
cerebellum have neurones that are most vulnerable to hypoxia-ischaemia (Paschen 
1989). Damage from ischaemia may occur in a graded fashion, depending on the 
collateral circulation surrounding the ischaemic ‘core’. This surrounding relatively 
ischaemic ‘penumbra’ may receive blood flow that is inadequate to preserve normal 
cellular function, but adequate to allow some level of recovery relative to the ischaemic 
‘core’ (Longo 1997). The concept of the ischaemic penumbra is important, as the 
compromised status of such a region may be improved if effective early intervention, 
such as delivery of a compromised fetus, is achieved (Obrenovitch 1995).
In conclusion, a fetus suffering from hypoxia initially compensates by producing energy 
through anaerobic metabolism and physiological neuro-protective mechanisms. At some 
stage, the fetus becomes decompensated and basic cellular functions fail. The neuronal 
loss occurs in two phases: during the primary hypoxic event and later during 
reperfusion/reoxygenation phase, with risks of permanent neurological morbidity and 
mortality.
1.1.3 Fetal adaptive response to hypoxia-ischaemia
Deficiency of oxygen (and the other nutrients) supplies antenatally have been shown to 
have an effect on body and organ growth in utero (Steyn 2000). Reduced oxygen supply 
to the fetus for most of the pregnancy will cause intrauterine growth restriction and 
potential subsequent long-term neurological handicap (Blair1993, 2000). At a cellular 
level, animal studies have shown that induced, prolonged placental insufficiency in the 
last third of gestation resulting in persistent moderate fetal hypoxaemia disrupt 
myelinasation and the growth of the cerebellum (Mallard 1998). They also show that, in 
mid -gestation, an episode of 12 hours hypoxaemia is enough to cause damage to white 
matter and neuronal death in the hippocampus, cerebral cortex and cerebellum (Rees 
1998).
In contrast, a normally grown term fetus is well adapted to the intermittent periods of 
hypoxia, which are frequently, if not universally, experienced during labour. The fetal 
circulation normally works at or near its functional limit with a high cardiac output. A 
limited improvement in cardiac output can occur, which is chemoreceptor-mediated, 
which results in an increase in fetal heart rate (Thornburg 1994).
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The cardiovascular response to acute moderate hypoxia in the ovine fetus is 
redistribution of the cardiac output, with an increase in blood flow to vital organs (brain, 
heart and adrenals) and a fall in blood flow to the carcass muscle, kidney and intestine 
(Peeters 1979, Jensen 1991 Ashwal 1984, Kiserud 2001). Decreasing breathing and 
gross body movements to reduce fetal metabolic activity will lower the oxygen demand 
(Bekedam 1985) and, as fetal haemoglobin has a higher oxygen affinity than in the 
adult, more oxygen can be attached to the haemoglobin molecule to be available for 
extraction by fetal tissue (Bocking 1992).
Other physiological mechanisms that may protect the brain are the release of 
catecholamines from the adrenal glands with activation of the sympathetic nervous 
system (Nylund 1979), utilisation of liver glycogen reserves (Irestedt 1984) and 
stressed-associated release of endorphins (Ionides 1995) and a rise in adenosine which 
may be neuroprotective (Newman 2001). Another described aspect of neuroprotection 
that is thought to occur is hypoxic or ischaemic ‘pre-conditioning’ in which tissues are 
rendered resistant to the deleterious effects of hypoxia-ischaemia by prior exposure to 
brief periods of hypoxia or ischaemia. However, the mechanisms of this phenomenon 
are poorly understood (Gidday 1994, Chopp 1989).
In contrast to the response to acute moderate hypoxia, severe hypoxia results in a fall in 
cerebral perfusion, as a result of a fall in perfusion pressure and cerebral 
vasoconstriction (Jensen 1987). In the sheep fetus the severity of histological brain 
injury correlates better with the degree of hypotension than of hypoxaemia, indicating 
that cerebral hypoperfusion is the central factor in the aetiology of hypoxic-ischaemic 
brain injury (Gunn 1992).
Similar findings have been described in the hypoxic human fetus using Doppler 
ultrasonography in the antenatal period (Vyas 1990). Fetal hypoxaemia, demonstrated 
by sampling umbilical venous blood, is associated with increased blood flow velocity in 
the middle cerebral artery, presumably as a protective mechanism enabling cerebral 
oxygen delivery to be maintained. As the fetal condition deteriorates further, the 
adaptive responses are overwhelmed and Doppler studies indicate the development of 
cerebral hypoperfusion. A partial failure of this redistribution and near terminal
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peripheral hypoperfusion. Table 1.1b provides a summary of the fetal pathophysiology 
events in response to acute and chronic insults.
Table 1.1b Summary of pathophysiological sequence of events
Fetal Exposure Anoxia (Minutes)
Hypercapnia 
Hypoxaemia 
Fetal response Compensation
Blood Pressure t
Cerebral blood flow I
Cerebral 02 Consumption ^
Outcome
Cerebral dysfunction None / minor
Brain damage q
Mortality 0
Hypoxia (hours) 
Respiratory acidosis 
Metabolic acidosis 
Decompensation
i
4-
4-
Moderate/severe
+
+
1.1.4 Clinical endpoints of brain injury
It is therefore hypothesised that the human fetus will show a similar cerebrovascular 
response to hypoxaemia during labour. Moderate hypoxaemia, which is relatively 
common phenomenon during labour due to impaired placental perfusion during uterine 
contractions, will lead to cerebral vasodilatation and a rise in cerebral blood volume. In 
contrast, severe hypoxaemia, such as may be found when uterine contractions are 
superimposed on an already inadequately functioning placenta, will lead to cerebral 
vasoconstriction and a fall in cerebral perfusion and blood volume. This results in 
intracellular failure and eventual brain cell death. If this sequence of events is to be 
detected during labour and the consequences in the neonate it is necessary to obtain 
continuous measurements of fetal cerebral oxygenation and perfusion.
Attempts have been made to define the association of the pathophysiological processes 
with clinical endpoints in the neonate and measurable variables in the fetus during 
labour in order to predict subsequent neurological outcome.
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Apgar scores
The Apgar score since its presentation in 1953 has been the most common end point 
defining intrapartum hypoxia (Apgar 1953). Apgar scoring is a quick and somewhat 
subjective method of assessing the condition of newborn infants. However, by 
themselves, Apgar scores have been shown to be poor predictors of neurological 
outcome and in particular, in preterm infants it is highly limited in this respect (Topp 
1997). Sykes et al (1982) reported the poor correlation between Apgar scores and 
umbilical artery acidaemia and Ruth (1988) found the sensitivity and the positive 
predictive value of a low 5 minute Apgar score (<7) were as little as 12 and 19%. 
However, it is known that the risk of poor outcome increases with decreasing Apgar 
score and increasing duration of low scores. Thus a 5 minute Apgar score below 4 but 
improving thereafter was associated with an increase in the risk of cerebral palsy from 
0.35 tol% for births in the 1950s and 1960s (Nelson 1981). It is thought now that the 
duration of low Apgar scores is more likely to indicate the effectiveness of resuscitation 
rather than predicting long-term neurological outcome (American Academy of 
Pediatrics 1996). More recently, it is thought that an Apgar score of 0-6 for longer than 5 
minutes is only ‘suggestive’ of intrapartum hypoxia (MacLennan 1999).
Metabolic acidaemia
Although its presence does not define the timing of its onset, metabolic acidaemia at 
birth is considered an essential criterion in defining a causal relationship between an 
intrapartum event and cerebral palsy (MacLennan et al 1999). Metabolic acidaemia may 
be detected from fetal, umbilical and neonatal blood samples. Attempts have been made 
to correlate pathological fetal acidaemia with an increasing risk of neurological deficit. 
Thus a pH of less than 7.00 with a base deficit of more than 16 mmol/1 have been 
suggested (Sehdev 1997) however cases of cerebral palsy with base deficits of between 
12-15 mmol/1 have been reported. Thus a base deficit of less than 12 is now considered 
to be an exclusion criterion (Low 1997) in defining a case of cerebral palsy to 
intrapartum hypoxia. Others have suggested that if both arterial and venous cord blood 
gases are obtained, then a difference in the partial pressure of carbon dioxide of more 
than 25mmHg suggest an acute rather than chronic acidosis (Belai 1998). However the
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technique of measuring both samples is crucial and is not universally practised 
(Westgatel994). Individual partial pressures of oxygen are not helpful as they correlate 
poorly with outcome (Belai 1998). However, acidaemia from neonatal samples may 
reflect difficult resuscitation and thus carry less weight in determining an intrapartum 
cause. Furthermore cord blood gas analysis is not universally practised, often only 
venous blood is obtained, and sodium bicarbonate, which is used as part of 
resuscitation, may influence the results of neonatal samples.
Encephalopathy
Samat and Samet (1976) originally described the term ‘hypoxic-ischaemic 
encephalopathy’ (HIE), the presence of which was shown to predict future neuro- 
developmental handicap. They described a specific condition with a typical course in 
the neonatal period, which included hypotonia, seizures and coma occurring within 24 
hours of delivery. However other causes of encephalopathy such as infection, 
hypoglycaemia, intra-cranial haemorrhage and metabolic disorders in the neonate need 
to be excluded before an intrapartum insult can be considered to be the cause of 
neurodevelopmental handicap (Nelson 1991). Furthermore, spastic quadriplegia and 
less commonly dyskinetic cerebral palsy are the only subtypes of cerebral palsy 
associated with acute hypoxic events (Rosenbloom 1994). However, even spastic 
quadriplegia is not specific to intrapartum hypoxia as in one population-based series 
24% of cases were not related to intrapartum events (Stanley 1993). MacLennan et al 
(1999) suggest that only early onset of severe or moderate neonatal encephalopathy in 
infants of more than 34 weeks gestation and cerebral palsy of the spastic quadriplegic or 
dyskinetic type should be considered in the causal relationship of intrapartum events to 
cerebral palsy. Thus, although HIE seems to be the best clinical endpoint for 
intrapartum hypoxia the condition is rare, with an incidence of 0.9 to 6.0 per thousand 
deliveries (Levene 1985).
More recently, MacLennan proposed a template of evidence required to suggest the 
occurrence of damaging intrapartum hypoxia was sufficient to cause permanent 
neurological impairment. Taken together, criteria 4 to 8 may help to time the hypoxic 
event to the intrapartum period.
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Table 1.2 Criteria suggesting that acute intrapartum hypoxia was the cause of 
cerebral palsy.
Essential criteria
1 Evidence of a metabolic acidosis in intrapartum fetal, umbilical arterial cord, or 
very early neonatal blood samples (pH <7.00 and base deficit >= 12 mmol/1)
2 Early onset of severe or moderate neonatal encephalopathy in infants of >=34 
weeks' gestation
3 Cerebral palsy of the spastic quadriplegic or dyskinetic type
Criteria that together suggest an intrapartum timing but by themselves are 
non-specific
4 A sentinel (signal) hypoxic event occurring immediately before or during 
labour
5 A sudden, rapid, and sustained deterioration of the fetal heart rate pattern 
usually after the hypoxic sentinel event where the pattern was previously normal
6 Apgar scores of 0-6 for longer than 5 minutes
7 Early evidence of multisystem involvement
8 Early imaging evidence of acute cerebral abnormality
1.2 CURRENT METHODS OF INTRAPARTUM SURVEILLANCE
Intrapartum surveillance methods should therefore aim to detect hypoxia when the fetus 
is still compensated with the aim of prophylactic intervention before the fetus becomes 
decompensated. However, due to the rarity of cases of intrapartum-related cerebral 
palsy, a large number of fetuses are required to detect an effect of an intrapartum 
monitoring tool on neurological outcome. Consequently, the majority of intrapartum 
studies have used surrogate clinical endpoints such as Apgar scores, SCBU admissions 
and obstetric intervention rates. The current methods available for intrapartum 
monitoring will now be reviewed.
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1.2.1 Fetal Heart Rate (FHR) monitoring
The association between the FHR and fetal well being was considered as early as the 
19th century. Laennec's invention of the stethoscope in 1806 was followed by 
auscultation of the fetal heart by Kergaradac. On hearing "beats occurring 143 to 148 
times per minute, and the patient’s pulse was only 72 beats per minute" he wondered 
"whether it would be possible to judge the state of health or disease of the fetus from the 
variations that occur in the beat of the fetal heart" (Pinkerton 1969). Normal fetal heart 
rates of 100 to 180 beats per minute were subsequently proposed and Schwartz 
recommended frequent counting of the fetal heart rate during labour, both during and 
between contractions, on the grounds that "asphyxic intoxication" could alter the rate 
(Goodlin 1979).
The presence of meconium-stained amniotic fluid and an abnormal FHR on auscultation 
were the criteria used for fetal distress until the introduction of continuous electronic 
monitoring of the fetal heart (EFM) through an electrode applied to the fetal scalp 
during labour (Hon 1960).
For the first time continuous traces were obtained, showing patterns that appeared to 
correlate with the condition of the baby at birth. Various fetal heart rate changes in 
relation to uterine contractions were described with terms such as "baseline 
bradycardia", "early and late decelerations" and "variable decelerations".
By the early 1970’s, reports on a decrease in perinatal mortality (Simmons 1974, 
Edington 1975) in units using electronic FHR monitoring led to the rapid uptake of 
EFM. The value of EFM, however was being questioned (Heilman 1965) and it was 
recognised that there was a need for ‘a controlled trial to determine whether FHR 
monitoring significantly alters perinatal morbidity and mortality’ (Renou 1974). 
Subsequently, the first controlled trial on the effects of EFM in high-risk labours did not 
detect any benefit, but showed an increased rate of caesarean section in women 
monitored continuously (Haverkamp 1976).
Several randomised-controlled trials of EFM versus intermittent auscultation were to 
follow. Thacker et al (1995) made a comprehensive review of 12 of these, and
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concluded that the only clinically significant benefit from the routine use of EFM was in 
the reduction of neonatal seizures. The rates of intrapartum and neonatal death, short­
term morbidity (with the exception of seizures) and long-term morbidity including 
cerebral palsy were found to be similar whether the fetal heart rate had been monitored 
continuously or intermittently. Follow-up of the children bom in the largest of these 
trials (Macdonald 1985), involving 13000 women, revealed that 78% of the cases of 
cerebral palsy had not shown clinical signs suggestive of intrapartum asphyxia (Grant 
1989).
Thus, it was thought that compared with intermittent intrapartum monitoring, intensive 
monitoring had little, if any, protective effect against cerebral palsy. More recently, 
Nelson (1996) reported that even the most severe FHR abnormalities of multiple late 
decelerations and decreased variability might have a false positive rate of 99.8% in the 
prediction of cerebral palsy. Thus the high frequency (up to 79%) of non-reassuring 
FHR patterns make both the decision on optimal management of the labour and the 
prediction of current or future neurological status of the fetus very difficult (Umstad
1994).
1.2.2 Fetal Blood Sampling (FBS)
In the early 1960s, Saling introduced the technique of FBS in response to the 1958 
Perinatal Mortality Survey which had shown that intermittent auscultation of the FHR 
had failed to prevent deaths caused by trauma and/or hypoxia in labour. This method of 
assessing the fetus during labour became established as a complementary assessment in 
cases of FHR abnormalities. A mean normal pH was established as 7.33 with a range 
(+/- 2sd) of 1.2-1.5 (Saling 1962). Corresponding values for umbilical cord pH at birth 
were 7.27(7.12-7.42) for the artery and 7.33(7.2-7.47) for the vein. Thereafter a pH 
value of 7.2 rapidly became established as the lower limit of normal and a value below 
this suggested a clinically significant acidaemia, with delivery of the fetus 
recommended (Beard 1971a).
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However, it was soon noted that in a "certain number" of neonates there was a 
discrepancy between the condition of the neonate predicted from the measured pH and 
its actual condition (Beard 1971b). The clinical value of FBS remains controversial as 
metabolic acidaemia is comparatively common (2 % of all births), and the vast majority 
do not develop cerebral palsy (Ruth 1988).
However, the more that EFM is supplemented with FBS, the lower the percentage of 
babies with pH at birth of less than 7.20 (Sykes 1983). This reduction in acidosis at 
birth however may have little value in the prediction of long term neurological outcome. 
Although a reduction in Caesarean Section rates may be achieved with CTG and FBS, 
there is little evidence of benefit in terms of short- term neonatal morbidity. Apart from 
a reduction in neonatal seizures, there is no evidence of benefit in the long -term with 
regards to a reduction in cerebral palsy (Grant 1993).
Furthermore, the use of FBS during labour is not without practical problems. Repeat 
samples are often necessary to establish a trend and caput succadaneum and amniotic 
fluid contamination can interfere with the results. Physiologically, the fact that the 
peripheral circulation is being sampled may lead to erroneous results as redistribution of 
the circulation occurs in hypoxia with peripheral vasoconstriction and increased blood 
flow to the brain and heart (Peeters et al. 1979).
Often difficulties are encountered in obtaining accurate and timely samples.
Furthermore, the economic consequences of maintaining analytic equipment, and the 
poor correlation between pH and neurological consequences, has led to the technique of 
FBS in routine use in only 50% of maternity units (Wheble 1989). Others question the 
feasibility of retaining this practice and propose that FBS should be removed from any 
possible association with purported 'standards of care' (Perkins 1997).
1.2.3 Pulse Oximetry
The use of pulse oximetry is routine in intensive care situations both on adults and 
neonates. The ratio of non-absorbed red light to near infrared light is measured to 
provide continuous, non-invasive data of peripheral arterial oxygen saturation of
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haemoglobin. The light is transmitted by two light-emitting diodes (LEDs) and detected 
by a photodiode that is on the opposite side on a finger or ear.
Over the last two decades, pulse oximetry has been adapted for fetal use with the use of 
sensors that rely on the reflectance of the emitted light and so incorporate the LEDs and 
the photodiode together. These sensors can therefore be applied to the fetal cheek or 
temple to avoid hair or caput, with the use of the Nellcor N-400 fetal pulse oximeter and 
the FS-14 sensor being the most frequently studied.
Several studies have evaluated the feasibility of fetal pulse oximetry and it’s use appears 
to be acceptable to mothers (Arikan 1998), with values of fetal oxygen saturation being 
obtained in up to 95% of studies, and sensor placement is considered to be easier than 
FBS (Gofmet 1997).
A wide range of normal values of fetal oxygen saturation has been obtained during 
labour. However, there is now general agreement that a fetal oxygen saturation value of 
30% represents the lower limit of normal (Chua 1997,East 1997, Kuhnert M 1998, 
Seelbach-Gobel 1999). This level has been shown to correlate with increased blood 
flow velocity in the middle cerebral artery in the human fetus during labour 
(Sutterlinl999). Using this level as a threshold seems to have the same predictive value 
for low arterial umbilical pH (7.15 or less) as a fetal scalp pH level of 7.20 (Carbonne
1997).
However, transient fetal arterial oxyhaemoglobin saturation values below 30% may 
occur during normal labour. Thus it is thought that the duration of values less than 30% 
better correlates with fetal compromise. Arterial oxygen saturation below 30% for at 
least 10 minutes has been correlated with scalp pHs of less than 7.20 (Kuhnert 1998). 
Bloom (1999) reported that saturations of less than 30% for at least 10 minutes 
correlated with either CS for non-reassuring fetal heart rate pattern, umbilical artery pH 
less than 7.20, admission to the special care nursery, and low 5-minute Apgar score.
The addition of pulse oximetry in cases of non-reassuring FHR patterns may improve 
the predictive value of CTG in terms of metabolic acidosis and neonatal resuscitation
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but has not been shown that its use is associated with a reduction in the overall 
Caesarean Section rate (Garite et al 2000).
There is therefore little evidence that the use of pulse oximetry reduces operative 
deliveries or long-term neurological handicap. This maybe because the number of 
fetuses detected by pulse oximetry suffering from hypoxia seems to be low (Luttkus
1998). Scalp perfusion may decrease in hypoxic fetuses who are peripherally 
vasoconstricted, thus reducing the size of the arterial signal in those fetuses that need to 
be monitored more closely. Furthermore, sensor placement still seems to be important 
as in one study, significantly lower values of oxygen saturation were found at the 
forehead compared with the fontanelle, the parietal and occipital position, and the 
temporal area. Thus, a difference of up to 13.4% in oxygen saturation may occur 
between the forehead and the occipital area (Dassell997).
1.2.4 Fetal Electrocardiograph (FECG)
Over the past decade, attention has focused on using the fetal ECG waveform as a 
discriminator of FHR changes. Many parts of the fetal ECG complex have been studied, 
most relate to the ST waveform and the PR interval.
Preliminary studies reported that intrapartum hypoxia may be associated with ST 
segment changes (Lewinsky 1992, Murphy 1992, Morgan 1991,Widmark 
1991,Westgate 1990,Arulkumaran 1990). Subsequently, a randomised trial 
incorporating ST segment analysis to assess its effect on obstetric intervention rates and 
neonatal outcome in over 2400 high-risk obstetric labours was undertaken (Westgate 
1992). It was reported that the addition of ST waveform analysis during labour 
significantly reduced the proportion of operative deliveries for presumed fetal distress 
with no detrimental effect on neonatal outcome. A large multi-centred study suggested 
that ST analysis, in addition to CTG, has a high sensitivity to predict fetal acidosis and 
is associated with a marked increase in positive predictive values compared with 
conventional CTG (Amer-Wahlin et al 2002).
Other studies, which analysed the PR interval, reported a relationship between the PR 
interval and the FHR, which varied according to the acid-base status of the fetus. Thus
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in the normal fetus there is a negative correlation between these two parameters and as 
acidosis develops, the relationship becomes positive (van-Wijngaarden 1996a).
A retrospective study (Reed 1996) reported that the use of this relationship may reduce 
unsuspected acidosis at birth by 50% and unnecessary FBS by 60% without an increase 
in the assisted delivery rate may be achieved. Subsequently, a randomised trial showed 
a significant reduction in the number of cases having an FBS performed without an 
increase in adverse outcome, when analysis of the PR-FHR relationship with 
conventional CTG was used (van Wijngaarden1996b). Unfortunately, however, the 
most recent and largest randomised study using FECG reported no difference in 
perinatal outcome (Strachan 2000).
1.2.5 Lactate measurement
As previously discussed in section 1.1.2.2, tissue hypoxia may lead to accumulation of 
lactate and hydrogen ions and therefore lactacidosis. Measurements can safely and 
easily be determined in fetal scalp and umbilical artery blood with a microvolume (5 
microliters) lactate meter (Nordstrom 1994). Mean values of fetal scalp lactate and 
umbilical artery lactate have been defined and intrapartum lactate measurements have 
been correlated with scalp pH and cord artery lactate (Nordstrom 1994, 1995. 2001). 
Significantly higher concentrations of lactate are found in scalp blood from babies with 
low Apgar scores compared with those with higher Apgar scores (Smith 1983). 
Westgren (1998) performed a randomised trial where scalp lactate was compared to 
scalp pH. The lactate group underwent significantly more successful blood sampling 
procedures and required fewer scalp incisions per blood sampling attempt. Umbilical 
artery lactate concentration blood may have the same predictive properties as pH or 
base deficit in relation to poor neonatal outcome (Westgren 1998).
Kruger et al (1999) found that that determination of the lactate concentration in fetal 
scalp blood is a more sensitive diagnostic tool than is determination of the pH value for 
predicting either an Apgar score <4 at 5 minutes or moderate to severe hypoxic- 
ischaemic encephalopathy. Similarly, lactate levels in the first hour of life and serial 
measurements of lactate appear to be important predictors of moderate-to-severe HIE
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(Shah 2004). The measurement of lactate in fetal scalp blood therefore appears to be an 
attractive alternative to pH analysis, and determination of the lactate concentration in 
fetal scalp blood seems to be a useful tool for monitoring the condition of the fetus.
1.3 Conclusion
Having considered the mechanisms of hypoxic-ischaemic brain injury and the available 
monitoring techniques it is possible to set down the requirements for the ideal method 
of fetal surveillance.
1) As the primary organ of concern is the fetal brain it is this that should be 
investigated. Studies on the peripheral circulation or fetal heart rate provide only 
indirect evidence of cerebral oxygenation and inferences concerning brain function 
may be misleading.
2) It has become clear that the aetiology of hypoxic-ischaemic brain injury is complex. 
Studying a single physiological parameter is unlikely to provide a complete picture 
of cerebral function. Information on brain oxygenation needs to be combined with 
knowledge of cerebral perfusion and possibly of cellular metabolism.
3) Because of the large fluctuations in cerebral oxygenation and haemodynamics that 
may occur during labour, single measurements may be misleading. Continuous 
measurements of fetal cerebral haemodynamics from the start of labour to detect the 
already compromised fetus entering labour would be of more value.
4) It is obvious that any fetal monitoring technique has to be acceptable to the mother. 
This means that it should be relatively non-invasive, safe and cause a minimum of 
discomfort to both mother and fetus.
5) In order to achieve widespread clinical use the technique needs to be cheap and easy 
to use.
6) Finally, it is vital that any new technique be subjected to rigorous testing, in the 
form of randomised trials, to establish it’s value as a means of fetal surveillance.
The development of the technique of near infrared spectroscopy for measuring 
intrapartum fetal cerebral oxygenation and perfusion will be considered against this 
background ideal method of fetal surveillance.
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CHAPTER 2
NEAR INFRARED SPECTROSCOPY (NIRS)
This chapter provides background information on the technique of near infrared 
spectroscopy and discusses how the technique has been applied to clinical practice. The 
limitations of current NIRS monitoring for intrapartum use and the development of a 
new technique of intensity modulated optical spectroscopy (IMOS) will be discussed. 
Finally the aims of the thesis will be presented.
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2.1 THEORETICAL BACKGROUND
The use of NIRS for intrapartum fetal use was based on two fundamental physical 
properties of near infrared light (Jobsis 1977).
a) Biological tissue is more transparent to light in the near infrared (650-900nm) 
part of the spectrum.
Photons in the near infrared part of the spectrum can therefore penetrate into biological 
tissue for distances of up to 8-9 cm (Cope 1988). This is in contrast to pulse oximetry, 
which uses light in the visible part of the optical spectrum that has a high attenuation in 
tissue. It is therefore only possible to study peripheral arterial saturation with pulse 
oximetry.
b) Oxyhaemoglobin (Hb02) and deoxyhaemoglobin (Hb) have characteristic 
absorption spectra in the near infrared light region.
The absorption spectra of both forms of haemoglobin are shown in Figure 2.1a. It is 
now possible to study the absorbing properties of haemoglobin alone by taking normal 
human blood, lysing the red cells and removing the cell membrane to leave a clear 
solution of haemoglobin. If the solution is reduced by equilibrating with 100% N2 and 
then fully oxygenated by bubbling with oxygen the different absorption spectra of Hb02 
and Hb can be elucidated (Wray 1988).
There are several important points to notice in the absorption spectra. Both Hb02 and 
Hb absorb far more light in the visible than in the near infrared part of the spectrum and 
it is this that makes biological tissue so much more transparent to near infra red light. 
Secondly, both Hb02 and Hb have different absorption characteristics in the near 
infrared region that enables them to be independently measured. They are also the only 
light-absorbing compounds or 4 chromophores’ present in the brain in variable 
concentrations. Those present at fixed concentrations (e.g. water, lipid) merely add to 
the overall absorption properties of the brain tissue whilst those with concentrations are
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oxygen dependent (e.g. haemoglobin) provide potentially useful information on tissue 
oxygenation.
There are other forms of haemoglobin which have specific absorption spectra in the 
near infrared region. Carboxyhaemoglobin may constitute up to 10% of haemoglobin 
content but its optical effect is negligible. Another form of haemoglobin, met- 
haemoglobin, which has a significant absorption in the near infrared is present in only 
small amounts at physiological pH and so may only contribute 1% of the haemoglobin 
signal.
During the course of fetal observations with NIRS a fixed amount of light will be lost 
due to absorption by chromophores whose concentration does not alter. This means that 
any change in near infrared light absorption will be due to a change in the 
concentrations of HbC>2 and Hb.
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Figure 2.1 The visible and near infrared specific extinction coefficient spectra of 
HbOz and Hb axe shown in a). The spectra in the near infrared region are depicted in a 
magnified form in b).
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2.2 CLINICAL APPLICATION
It was Jobsis, at Duke University, Carolina who in 1977 first put this information 
together using a sensitive spectroscopy system, which used only near infrared 
wavelengths, to measure changes in brain oxygenation in the cat (Jobsis et al 1977). 
Although most of the work from the Jobsis group was on the application of this 
technique to physiological studies in laboratory animals it was his system which formed 
the basis of clinical NIRS.
2.2.1 Neonatal use
Before the technique of NIRS was applied for use on the fetus during labour, most of 
the publications described measurements of cerebral oxygenation and haemodynamics 
in the neonate. It is possible to transmit near infrared light through the head of a term or 
preterm infant and so make spectroscopic measurements across the entire thickness of 
the brain. This is because the surface tissue and skull are thin and so contribute little to 
the overall signal.
The first work on the clinical application of near infrared spectroscopy was published in 
1984 by Ferarri and Giannini and in 1985 by Brazy and Jobsis. These clinical data were 
mainly from preterm infants and described changes in the cerebral concentrations of 
oxyhaemoglobin and deoxyhaemoglobin during induced fluctuations in cerebral 
oxygenation. Subsequently, quantifiable changes in neonatal cerebral concentrations of 
HbC>2 and Hb have been reported (Wyatt 1986, Edwards 1988). Wyatt et al (1990) then 
reported on a method for measuring cerebral blood volume (CBV) using NIRS. In 
infants undergoing intensive care, but were thought to have normal brains, mean CBV 
was 2.2 +/- 0.4 ml.lOOg'1. In contrast, infants who had evidence of brain injury (mostly 
hypoxic-ischaemic) had a significantly elevated CBV of 3.0+/- 1.0 ml.lOOg’1, 
suggesting that cerebral vasodilatation leading to elevation of CBV is a frequent 
occurrence following hypoxic-ischaemic brain injury. However, these methods involve 
eliciting small changes in cerebral blood volume by changing pC0 2  concentration 
through alterations in the ventilation rate.
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2.2.2 Fetal use
As discussed in chapter 1 the perceived need to measure cerebral oxygenation and 
perfusion led several groups to investigate the potential role of NIRS to provide 
information on fetal brain haemodynamics during labour.
The two main centres that used NIRS during labour were University College, London 
and Keele University, Stoke. Commercially available NIRS monitors were 
(Hamamatsu Photonics KK (Japan), Radiometer/ Keele University (Denmark/ UK), and 
Critikcon (UK)).
Specially designed optical fibres have been attached to the fetal head either hand-held 
through an amnioscope (Schmidt 1990), as a hinged optode (O'Brien 1993) or mounted 
in silicone rubber (Peebles 1993) to transmit and receive light to and from a NIRS 
spectrophotometer.
Early studies on human fetuses by Peebles et al (1992a) used the NIRO 500 
spectrophotometer (Hamamatsu Photonics KK, Japan, see figure 2.2). This provides a 
light source comprising four laser diodes, emitting near infrared light at 775,825,850 
and 904nm wavelengths (sequentially pulsed at 1.9kHz, with a pulse width of lOOnsec). 
The power output of the lasers varies with their operating temperature. Although it is 
recommended that 30 minutes should elapse after switching on the lasers, before 
measurements are made, accurate measurements can be made from the time that the 
optodes are in place if the lasers are turned on many hours before the study.
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Figure 2.2 NIRO 500 on an equipment trolley
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A photomultiplier tube within the spectrometer detects transmitted light. A controlling 
computer calculates a mean value for the amount of light detected at each wavelength 
over the chosen sample time (operator selective, ranging from 0.5 s to 60 seconds).
Following baseline measurements the change in light intensity (or attenuation) for each 
sample, relative to the baseline attenuation is then derived.
The change in intensity of the near infrared light can be subsequently used to calculate 
changes in Hb and HbC>2 concentration. This calculation can be done in real time to give 
a visual indication of the relative changes in oxygenation at the bedside.
Changes in the concentrations of Hb and HbC>2 are calculated from the changes in 
attenuation (defined as the logarithm (base e) of the ratio of incident and detected 
intensities) using a modification of the Beer-Lambert Law (Delpy et al. 1988):
A c = AOD/(a.B.L)
where OD is the tissue attenuation of the infrared light (units of optical density), a is the 
extinction coefficient of the chromophore (/mmol per cm), c is the concentration of 
chromophore (mmol/1), L is the distance between the point of light entry and exit (cm), 
and B is a pathlength factor that takes account of the scattering of light in tissue, which 
causes the optical pathlength to be greater than L. The extinction coefficients of HbC>2 
and Hb are known (Wray 1988) and a mean value for B of 4.99 was used (Duncan
1995).
Using the NIRO 500 spectrophotometer, a silicone rubber probe and the above method 
of calculation of Hb and Hb02, Peebles et al at University College, London applied the 
technique of NIRS to study changes in human fetal cerebral oxygenation during labour.
2.2.2.1 Effect o f uterine contractions
The first report on changes in human fetal cerebral haemoglobin concentration and 
oygenation during labour measured by NIRS was in 1992 by Peebles (1992b). He
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compared the effects of uterine contractions with and without fetal heart rate 
decelerations in eight singleton term fetuses. In six of eight fetuses normal uterine 
contractions were associated with proportional decreases in both oxyhaemoglobin and 
deoxyhaemoglobin and a fall in cerebral blood volume without desaturation of cerebral 
haemoglobin. Mean cerebral haemoglobin oxygen saturation calculated during normal 
contractions was 43% +/-10% (SD). Contractions with fetal heart rate decelerations 
produced different results in that oxyhaemoglobin fell but deoxyhaemoglobin rose, 
indicating cerebral desaturation. Figure 2.3 illustrates these two different patterns.
From these data, Peebles suggested that the change in total haemoglobin concentration 
observed during normal uterine contractions probably reflected a balance between direct 
pressure effects, reducing cerebral blood flow and obstruction of venous drainage. The 
usual change in cerebral blood volume observed with normal contractions implied a fall 
in total cerebral blood volume of 30%, assuming neonatal values for cerebral blood 
volume (Wyatt 1990). Peebles hypothesised that the reciprocal changes in 
oxyhaemoglobin and deoxyhaemoglobin during contraction associated with fetal heart 
rate decelerations indicated transient desaturation of haemoglobin within the brain. This 
may have been due to a transient desaturation in the umbilical venous supply which 
was transmitted to the brain, or conversely it may have indicated a reduction in cerebral 
blood flow, secondary to fetal bradycardia, leading to increased oxygen extraction 
within the brain.
2.2.2.2 Effect o f frequency o f uterine contractions
Peebles (1994) found that a significant fall in HbC>2 with a rise in Hb occurred with a 
short contraction interval (< 2 minutes). This again suggested there was a transient 
desaturation of the fetal brain. Furthermore, the changes in HbC>2 were positively, and in 
Hb negatively, correlated with the time interval between contractions. A mean 
contraction interval of 2.3 minutes was found below which the Hb02 concentration 
usually fell and that of Hb rose, indicating a fall in cerebral haemoglobin saturation. 
Conversely, longer contraction intervals were associated with findings indicative of a 
rise in cerebral haemoglobin saturation.
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Figure 2.3 Changes from an arbitrary baseline in the cerebral concentrations of Hb02 
{dotted line\ Hb {dashed line) and total haemoglobin {solid line) in the same fetus 
during a) 2 normal contractions and b) a contraction during a FHR deceleration. 
Reproduced with permission from Peebles (1992b).
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2.2.2.3 Changes with FHR decelerations
Subsequently, Aldrich (1995a) using the same spectrometer and fetal probe as Peebles 
set out to determine the relationship between contraction related changes in fetal heart 
rate and cerebral oxygenation. The changes in fetal cerebral HbC>2 and concentrations 
that occurred during contractions were quantitatively similar, irrespective of the fetal 
heart rate changes. However, late fetal heart rate decelerations were associated with a 
significantly greater fall, after the uterine contraction, in the mean concentration of 
HbC>2 of 0.52 mmol/100 g and a significantly greater rise in the mean concentration of 
Hb of 0.36 mmol/100 g.
2.2.2.4 Effect o f second stage o f labour and delivery
Aldrich et al (1995c) then used NIRS in the second stage of labour to show that the 
onset of pushing was associated with a significant decrease in SmcC>2 and a rise in HbT 
(and thus cerebral blood volume). Following the onset of maternal pushing, the mean 
Hb concentration increased by a mean of 0.79 mmol. 100 g-1 without any consistent 
change in the HbC>2 concentration. These changes were associated with a significant 
decrease in the calculated mean cerebral oxygen saturation from a mean of 46.8% to 
38.1%. Pushing was also associated with a significant increase in the mean cerebral 
blood volume, which rose, by a mean of 0.33 ml. 100 g-1.
Further studies during delivery, showed that with the onset of respiration, HbC>2 rose 
rapidly with reciprocal changes in Hb, indicating a rapid rise in cerebral oxygenation. In 
response, cerebral blood volume fell, suggesting the onset of cerebral vasoconstriction 
(Peebles 1992a, Schmidt 1994).
2.2.2.5 Acid-base correlation
In relation to clinical end-points, SmcC^ measurements thirty minutes prior to delivery 
correlated with pH in both umbilical vessels (Aldrich 1994a) and HbC>2 correlated with 
pC> 2 measured by FBS (Schmidt 1990a).
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2.2.2.6 Other fetal studies
Changes in fetal cerebral oxygenation have also been described in response to changes 
in maternal posture during labour, maternal oxygen administration and in fetuses with a 
nuchal cord (Aldrich 1994b, 1995b, D'Antona 1995). A case report by Peebles (1991) 
demonstrated a fall in HbC>2 and a rise in Hb, occurred in response to uterine 
hyperstimulation from the inappropriate use of oxytocin.
2.2.2.7 Animal studies using NIRS
These reports on the changes in cerebral haemodynamics in human fetuses appear to be 
similar to those found in the sheep fetus to investigate the cerebral response to 
hypoxia/ischaemia in a controlled manner. Induced hypoxia, in near-term fetal sheep, is 
associated with a sustained increase in cerebral blood flow and CBV (Bennet 1998). This 
is associated with a decrease in the metabolic rate, with no change in oxygen delivery 
and a fall in oxygen consumption (Newman 2001). CBV also increases in response to 
acute moderate asphyxia, induced by occlusion of the maternal common internal iliac 
artery, with a fall in brain oxygen delivery and consumption (Newman 2000). 
Conversely, acute umbilical cord occlusion, to induce an asphyxial state, is associated with 
a fall in cerebral blood flow but without a decrease in CBV (Bennet 1998). Post-asphyxia 
NIRS data suggests that there is a significant secondary reduction in CBV along with a 
reduction cerebral blood flow and oxygenation despite normal perfusion pressure and 
heart rate (Bennet 1999).
2.3 Limitations of conventional NIRS
NIRS therefore has the unique ability to provide measurements of cerebral saturation 
and changes in CBV from within the brain itself. As mentioned in section 2.2.2.7, data 
from animal studies suggest that measurement of CBV may provide a better reflection
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and sensitivity to the type, severity and timing of the insult to which the fetus is 
exposed.
On the basis that the initial fetal response to acute hypoxia is cerebral vasodilatation and 
an increase in cerebral blood flow, knowledge of absolute blood volume might help 
distinguish the normoxic from the hypoxic fetus. By providing this information during 
labour, NIRS has the unique potential to detect the fetus at greatest risk of irreversible 
brain injury during labour.
Although NIRS is a promising new method of fetal surveillance, the technique used to 
date is limited in the clinical setting. This is because, firstly, interpretation of results 
using intrapartum NIRS is hampered by the fact that the technique provides information 
about changes in CBV, derived from changes in the concentration of HbC>2 and Hb 
which are calculated from an arbitrary baseline set at the beginning of the study. It is 
therefore not currently possible to quantify absolute CBV, and therefore the degree of 
cerebral vasodilatation, at the beginning of the study. Furthermore, the method for 
measurement of cerebral saturation (Smc02) relies on parallel changes in HbC>2 and Hb, 
which do not always occur during labour.
Secondly, the measurements of cerebral saturation that have been described may be 
affected by changes that occur within the fetal probe used, in response to uterine 
contractions. This was suggested by Hamilton et al (1995) at North Staffordshire 
Hospital. They reported that Smc02 measurements using NIRS were possible from the 
brain of a dead fetus during labour. Hamilton argued that because there was no 
possibility of a change in cerebral oxygenation in a dead fetus, the apparent 
concentration changes recorded were likely to be due to movement artefact, resulting 
from changes occurring induced by contractions within the fetal probe.
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2.4 INTENSITY MODULATED OPTICAL SPECTROSCOPY (IMOS)
The main aim of this study was to try to overcome these limitations of NIRS. Recent 
advances in optical technology means that the infrared signal can be manipulated, using 
a technique called Intensity Modulated Optical Spectroscopy (IMOS).
This section explains the materials and methods that were used in this thesis to provide 
measurements of absolute concentrations of Hb and Hb02 in biological tissue using the 
new infrared technology of IMOS. The theoretical background to IMOS to derive these 
measurements are described and then the materials required for the collection and 
analysis of data using this new optical technique.
2.4.1 Theoretical background to IMOS
The conventional NIRS monitor (Hamamatsu Photonics KK, Japan) used by Peebles 
(1993) and Aldrich (1994c) to measure changes in fetal cerebral blood volume and 
saturation, used near infrared light that was emitted from laser diodes in short pulses. 
When the laser is switched on the brightness, or intensity, is constant.
When the light was passed through the fetal head, the detected change in intensity by 
the spectrometer allowed calculation of changes in the concentrations of fetal cerebral 
oxy and deoxyhaemoglobin. These measurements were derived from the measured 
changes in the attenuation of near infrared light (defined as the logarithm (base e) of the 
ratio of incident and detected intensities) using a modification of the Beer-Lambert Law 
(Delpy et al. 1988), previously described in section 2.2.2.
Using newer infrared technology it is now possible to modulate the near infrared light 
source into an ultra-high frequency sinusoidal waveform. The waveform has AC and 
DC components as illustrated in figure 2.4a.
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Figure 2.4a Schematic representation of an intensity modulated light source.
To fetal brain
Intensity
change AC
From fetal brain
A C
Phase change
Time
Figure 2.4b Simplified diagram of the changes in an intensity modulated light source 
before and after passing through the fetal brain.
If this light source is passed through the fetal brain changes in the waveform will occur. 
The intensity will change similar to conventional NIRS. In addition, as can be seen in 
figure 2.4b, the waveform is out of step or ‘out of phase’ with the original incident light 
and the ac and dc component (the ratio of which is defined as the modulation depth) of 
the modulated light wave will change.
Therefore in addition to attenuation (derived from intensity), changes in the phase and 
modulation depth occur.
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2.4.2 Absolute fetal Hb and HbC>2 derivation with intensity modulated light source.
In simple terms, the absorption properties (termed the absorption coefficient (pa)) of the 
fetal brain at near infrared wavelengths is composed of the absorption properties of its 
constituent components. As previously described in section 2.1, the absorption 
properties of biological tissue are largely composed of HbC>2 and Hb. Variations in 
refractive index are responsible for the scattering of light in tissue. Biological tissue also 
has scattering properties (defined as the scattering coefficient) and is dependent on 
variations in the collective refractive indices of the tissue constituents. These optical 
properties of scattering media (pa and ps) determine the attenuation of light diffusely 
reflected from a medium as well as the phase and modulation depth of an intensity 
modulated light wave. If there are changes in the tissue absorption coefficient changes 
in light intensity (attenuation), phase and modulation depth will occur.
From these changes it is possible to derive the absolute absorption coefficient of a 
medium the measurement of which is independent of scattering.
These measurements are possible because the ratio of the attenuation and phase (defined 
as Q in this thesis) is a linear function of pa (and hence concentration) only.
This is also true for the ratios of attenuation with modulation depth and phase with 
modulation depth (similarly, defined as R and V). This linear function is based on 
diffusion theory, which is described in detail in appendix 1. (Kohl 1997)
From these measured absolute absorption coefficient (pa), absolute concentrations of Hb 
and HbC>2 can be derived in biological tissues as the extinction coefficients of these 
chromophores for the laser wavelengths are known.
Thus
=8Hb02X[Hb02] + eHbX[Hb] 
where pax is the absorption coefficient at wavelength of NIR light X of the tissue under 
investigation, and 0 HbO2 and 8 HbX are the known extinction coefficients at wavelength X 
for HbC>2 and Hb respectively. The product of the extinction coefficient (e.g. 8 nb0 2 ) and 
absolute concentration (e.g. HbCh) at a certain wavelength is the absorption coefficient 
of a chromophore. Hence, if two or more wavelengths (X\ and A,2 ) are used, absolute 
concentrations of HbC>2 and Hb can be derived by solving two simultaneous equations 
as follows:
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If absolute concentrations of HbC>2 and Hb are calculated, then the following simple 
equations can derive absolute total haemoglobin (HbT) and cerebral saturation (SmcCh):
HbT = [Hb02] + [Hb]
Smc02 = 100% * [Hb02] / [Hb02] + [Hb]
Cerebral Blood Volume is directly related to HbT by the following equation and 
therefore an estimate of absolute CBV can be derived:
CBV = HbT x MWHbxlO-6/ tHb x 10'2 x D, x 10 (Elwell 1995)
where MWHb is the molecular weight of haemoglobin (64500), tHb is the mean 
umbilical vein Hb concentration (16.8g/dl) (Wintrobe 1997) and Dt is the brain tissue 
density (1.05g/ml).
2.4.3 Optical Pathlength measurement
As previously described in section 2.2.2, conventional NIRS assumes that the optical 
pathlength remains constant. In these measurements, based on the Beer Lambert law, 
optical pathlength is a product of the interoptode spacing (IOS) and a differential 
pathlength factor.
However, IMOS has the unique ability to provide information on the changes in the 
optical pathlength during studies in biological tissue. This is because the change in 
phase (that can be measured by an intensity modulated optical spectrometer) is inversely 
related to the change in optical pathlength, which can be calculated, from the following 
equation:
Ad= - AOc/27uivm.
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where AO is the change in phase of a lightwave, intensity modulated at a frequency vM 
(200MHz) c is speed of light in a vacuum and n is the refractive index of tissue (1.4).
Thus the technique of IMOS has the unique ability to provide absolute concentrations of 
Hb02 + Hb in biological tissue and provide information on the optical pathlength.
2.4.4 Clinical equipment
In order to put the theory of IMOS in to practice, the principle equipment required are a 
spectrometer that modulates at least two different wavelengths of infrared light sources 
and optical fibres to transmit and receive the light via a specially designed probe.
The spectrometer
In 1991 the Wellcome Trust funded the development of the intensity modulated optical 
spectrometer at Department of Medical Physics and Bioengineering, University 
College, London. (Wellcome Trust Ref033126/Z/91,Duncan et al 1993). This 
spectrometer was based on an original design by Chance et al (1990).
This spectrometer has a purpose built unit that holds the laser diodes (Delta 
Development Ltd), of which there are four lasers at the wavelengths 741nm, 787nm, 
815nm and 856nm (Seastar Ltd) with a variable mean output powers between 6 and 
40Mw. The NIR light is provided by two phase locked frequency synthesisers (PTS Ltd 
model 500). A second modulation frequency offset from the first, typically by 10kHz, is 
also available to facilitate cross-correlation of later signals within the mixers (see figs
2.5 and 2.6). The signals are mixed, filtered (Mini Circuits, ZAD-1 WSH & BLP-10.7) 
to produce a modulation frequency of 200mHz. This is the frequency in which the 
optical pathlength derived from the phase will be equal to that derived from time of 
flight measurements (Arridge 1992).
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A counter card provides timing pulses, enabling each of the lasers to be turned on in 
sequence for 20ms at 100ms intervals. Four separate optic fibres are then required to 
form a bundle, which can be sheathed in Kevlar, to carry light to and from a sample. 
The photomultiplier tube (PMT, R4998, Hamamatsu Phototonics KK), detects the 
signal that reaches the spectrometer from a sample. This signal consists of two 
components, DC intensity and the AC amplitude which are filtered and amplified. By 
simple arithmetic, using the X and Y co-ordinates of the AC amplitude and the DC 
intensity, the attenuation, phase shift and modulation depth can be derived. Readings 
can be taken every half-second during which each laser is fired five times. An analogue 
card in the PC allows up to eight external analogue channels to be monitored and these 
may also be displayed.
Frequency synth 1
Phase locked
Frequency synth 2
Mixer
Dual phase
AC
X
Lockin Amp
Mixer Amp PMT
________ DC
Integrators 
Demultiplexer 
LD Multiplexer
Laser driver
SAMPLE
Computer
Figure 2.5 Schematic diagram of the intensity modulated optical spectrometer.
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Figure 2.6 The components of the intensity modulated optical spectrometer (A is the 
visual display, B is the laser compartment also containing the synthesisers and mixers 
and C is the PMT compartment).
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2.4.5 Safety of IMOS
Maternal and fetal safety is of obvious prime importance when applying a new 
technique for intrapartum surveillance in the research setting. Safety can be considered 
under the following headings:
Electrical
Electrical isolation of the mother and fetus is simple as glass optical fibres are the only 
connection between patient and instrument.
Laser safety
Output of the lasers is approximately one order of magnitude below the safety limits 
recommended by the electro-technical committee regulations. There is therefore no 
possibility of light-induced changes to the brain, skin or eye, even if the transmitting 
optode was placed accidentally directly over the orbit.
Mechanical safety
Any object placed against the fetal head and maternal tissues during labour will be 
forced against the fetal scalp by pressures of up to 150mmHg (Svenningsen et al 1988). 
It is therefore important that a probe should not have any sharp edges or comers that 
could cause local trauma. The only hard elements in the probes are the resin potted glass 
prisms. However, these are almost completely encapsulated in silicone mbber, apart 
from the smooth prism face which made contact to the fetal scalp.
2.4.6 Data analysis
In order to calculate absolute concentrations from the measured changes in attenuation, 
phase and modulation depth it is necessary to have the equations readily available. 
These were therefore incorporated into the notebook which was developed at the 
Department of Medical Physics, UCL, which runs in the Mathematica™ version 3.01 
programme (Wolfram Research Inc, Champaign, Illinois, USA) (see appendix 1).
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This programme displays
a) continuous changes in attenuation, phase and modulation depth for each laser 
wavelengths
b) changes in Hb02 and Hb (calculated from the changes in attenuation using 
conventional NIR techniques)
c) Q, R and V ratios (expressed as first order regression lines, graphically and 
numerically)
d) Measured absolute absorption coefficients and absolute concentrations
e) Data from collected from the external analogue channels ( such as FHR and 
contractions)
The display of c), d) and e) are obtained when an observer selects two different time
points in the data in a) and runs the programme.
2.4.7 Measurements with IMOS to date
Duncan (1995) used the spectrometer and specially designed probes to measure optical 
pathlength on the adult head, calf and forearm and the head of the newborn infant. 
These correlated well with more established methods of measurement. Duncan also 
investigated its preliminary use on a light-absorbing tissue simulating medium with 
known optical properties. The absolute experimental values of the absorption coefficient 
were found to be approximately twice that of the known values. It was thought that 
more accurate measurements could be made with improved design and operation of the 
spectrometer. Further technical improvements allowed Kohl et al (1997) to undertake a 
similar study. He was able to calculate absorption coefficients of a light absorbing 
compound with uncertainty of only 4-6%.
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2.5 CONCLUSION
Based on the described studies using conventional NIRS and the preliminary results 
using IMOS, it is clear that IMOS has the remarkable potential to
a) overcome the limitations of conventional NIRS found during intrapartum studies 
and
b) provide measurements of absolute CBV and cerebral saturation in human fetuses 
during labour.
Thus, the hypothesis of this thesis was that these measurements were different in 
normoxic fetuses compared with hypoxic fetuses during labour. The objective was to 
compare CBV and cerebral saturation in normoxic and hypoxic fetuses using IMOS.
The principle aim of the work on which this thesis is based was to obtain absolute 
concentrations of Hb(>2 and Hb in human fetuses during labour, using the described 
technology of IMOS.
If IMOS is capable of providing this information from the onset and the duration of 
labour, it has the unique potential to detect the chronically compromised hypoxic 
fetuses entering labour and to define those intrapartum events that require obstetric 
intervention to prevent irreversible brain injury and subsequent long-term neurological 
handicap.
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CHAPTER 3
OPTICAL PHANTOM STUDIES
Previous experience at UCL with NIRS and IMOS showed that the recruitment of 
mothers in early labour into studies were easier with the commercially available NIRO 
500 clinical instrument compared with the IMOS instrument. This was attributable to 
the necessity of having an extra (clinically non-qualified) person in the delivery suite to 
operate the IMOS system. Furthermore, the IMOS system was a prototype, the 
components of which were extremely fragile. Components such as the PMT and a 
higher resolution analog to digital converter to reduce system noise were updated before 
the start of fetal studies. It was therefore necessary to study the optical performance of 
the current IMOS system before fetal studies were undertaken. It was also hoped that 
my experience gained with the IMOS system during these studies would negate the 
need for an extra person to be present during the proposed fetal studies.
This chapter describes the optical phantom studies that I performed within the 
Department of Medical Physics at UCL. The aims of these studies were to (a) assess the 
current optical performance of the spectrometer and compare this with that found by 
Kohl (1997) using light absorbing tissue-simulating media (optical phantoms) and (b) to 
provide information to optimise the data collection and analytic process of IMOS during 
studies on human fetuses during labour.
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3.1 STUDY 1- MEASUREMENT OF ABSORPTION COEFFICIENT IN AN 
OPTICAL PHANTOM.
3.1.1 Introduction
As described in chapter 2, the new optical technique of intensity modulated optical 
spectrometry has the potential to provide absolute measurements of fetal cerebral 
haemoglobin concentrations. However, the technique relies on the absolute 
measurement of the light-absorbing properties of the medium under investigation. By 
using the spectrometer and specially designed optical probes, which contain the optical 
fibres to transmit and receive near infra red light, it is possible to collect data from 
specially constructed mediums, known as optical phantoms. These are designed so that 
they have absorbing properties similar to biological tissue. As described in chapter 2, 
the measurement of absolute concentrations of haemoglobin require the absolute 
measurement of the absorption coefficient (pa) of the tissue. It is therefore possible to 
obtain measurements of absorption coefficient of optical phantoms in a controlled 
manner within the laboratory to provide information on the accuracy of the 
measurements of the spectrometer. By using such light-absorbing, tissue-simulating 
media that have similar optical properties to biological tissue, and the spectrometer 
described in this thesis, Kohl et al (1996,1997) reported that the uncertainties of their 
measurements of absolute absorption coefficient were as little as 4-6%.
However, in contrast to other more established intrapartum monitoring techniques, the 
spectrometer used in this thesis was a prototype. Technical improvements in the design 
of the spectrometer’s hardware were ongoing. Since the reporting by Kohl, the 
spectrometer had been updated with a new PMT, a higher resolution analog to digital
Timconverter card, laser diodes and the specially designed Mathematica notebook for 
data analysis had been developed.
This study therefore set out to determine the accuracy of the measurements of the 
updated spectrometer in a controlled manner using an optical phantom which had
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known absorption properties. The aim was therefore to derive measurements of the 
absorption coefficient of the optical phantom and compare these to the known 
absorption coefficients.
3.1.2 Methods
Data collection
The optical phantom used in this study was an intralipid emulsion. This consisted of 
phospholipid micelles (soybean oil, glycerine and lecithin) that was diluted to 1 part in 
100 with water (1 % lipid, and 99% water) to a volume of 450 ml. This optical phantom 
has previously been described by Staveren (1991) and Flock (1992) and hence it’s 
absorption properties are known. Within the emulsion two optodes were placed 35mm 
apart just under the surface and held in place by a specially designed clamp (see figure 
3.1).
Laser input
To PMT
Scattering o f  NIR 
light in the solution
Beaker o f  450 ml o f  1% intralipid 
solution and ‘x ’ amount o f  dye
D=35m
Figure 3.1 Diagram to show experimental set up for study 1.
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Near infrared light, generated by the semiconductor lasers at the four discrete 
wavelengths and modulated at 200 MHz, was carried to the intralipid emulsion by four 
single mode optical fibres. Light emitted from the emulsion was carried by a bundle of 
approximately two thousand 50pm diameter multi-mode fibres to the new 
photomultiplier tube housed within the spectrometer. The optodes were covered with 
black cloth to avoid interference from background light.
An infrared absorbing dye (Pro-Jet, Zeneca), which has absorbing properties similar to 
that of biological tissue, was added to the intralipid emulsion in a continuous fashion via 
a syringe pump.
To allow a continual increase in the concentration of the dye (which increases the 
absorption coefficient) within the medium, a specially designed peristaltic pump was 
used. This re-circulated the solution in the container at a rate of 0.22 litres every minute 
to provide efficient mixing of the contents to produce a homogenous solution with 
respect to infused dye and intralipid. Data was collected over a period of 120 minutes as 
the concentration of the dye, and thus absorption coefficient, was continually increased.
Data analysis
Data were analysed at 10 second intervals (n = 22) to allow calculation of the absorption
• Tikicoefficients of the Projet dye using the specially designed Mathematica notebook. 
These were calculated at the four laser wavelengths, using the three previously 
described ratios (Q, R and V). These calculations were then compared with the true 
absorption coefficient of the medium, which were derived using a previously 
established algorithm (Staveren 1991) (see appendix 2).
3.1.3 Results
Figure 3.2 illustrates the effect of the continual increase in the ProJet dye on 
attenuation, phase and modulation depth of the intensity-modulated light during the 
study at laser wavelength 787nm. Similar data were obtained at the other three laser 
wavelengths.
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As can be seen, an increase in dye concentration is associated with an increase in all 
three variables. The sudden ‘dips’ in the data represent manual increases of the PMT 
sensitivity to increase the detection of light as the absorption properties of the medium 
increased. Figures 3.3 illustrate the relationship between the calculated absorption 
coefficient by the Mathematica notebook and true absorption coefficient measured at 
the four different wavelengths and the ratios with regression lines, coefficient of
'y
regression and correlation coefficients (R ).
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Figure 3.2 Effect on attenuation, phase and modulation depth of a continuous increase 
in the absorption coefficient in the liquid optical phantom at wavelength 787nm.
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Figure 3.3. Calculated absorption coefficients by IMOS versus the true absorption 
coefficients using attenuation and phase (Q) at the four wavelengths (856,815, 
787,74 lnm,above to below) with regression lines, coefficient of regression and 
correlation coefficients (R )
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Table 3.1 summarises the calculated error of these measurements of absorption 
coefficients using the different ratios described in chapter 2.
Table 3.1 The error of the calculated mean absorption coefficient (% of the mean 
true absorption coefficient) at each laser wavelength for each ratio.
Wavelength Q R V
856nm 3.0 26.0 21.7
815nm 7.7 58.0 58.0
787nm 4.8 40.1 28.4
741nm 8.3 11.1 20.7
3.1.4 Discussion
This study shows that the updated spectrometer and the new specially designed 
Mathematica notebook allow calculation of the absolute absorption coefficient of a 
compound within an optical phantom, the optical properties of which are similar to 
biological tissue. Absolute absorption coefficients were calculated from the different 
ratios of attenuation, phase and modulation at all four laser wavelengths. It is this 
calculation of the absolute absorption coefficient of a compound, such as haemoglobin 
in the fetal brain that is required to provide the absolute concentration.
However from these data there appears to be a wide discrepancy in the accuracy of 
these measurements between the different lasers and between the different ratios. 
Correlation of the calculated measurements with the true values of absorption 
coefficients suggests that the most accurate method is the Q (attenuation and phase) 
ratio at 856 and 787nm wavelengths of light. The errors of measurement were less than 
10% at all four wavelengths. Using modulation depth and phase (V) gave the least
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reliable results. This may reflect the quality of the individual optical fibres transmitting 
the infrared light but is more commonly due to the high signal noise on the modulation 
depth data, which has also been reported by Kohl (1996,1997).
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STUDY 2- SIGNAL-NOISE CHARACTERISTICS OF THE SPECTROMETER.
3.2.1 Introduction
It is clear from study 1 that even in a controlled laboratory manner the accuracy of 
IMOS measurements is variable. When applied to the human fetus, the unpredictability 
of labour and the intrapartum events that may occur not only have an effect on data 
collection but also reflects the available time in which a new intrapartum method of 
fetal surveillance can be potentially employed. The commercially available NIRS 
monitors (Hamamatsu Photonics KK (Japan), Radiometer/ Keele University (Denmark/ 
UK), and Critikcon (UK)) required a ‘warming-up’ period of approximately two 
minutes (Elwell 1995). This allowed Peebles (1993) and Aldrich (1994) monitored 
fetuses in labour with NIRS from 35 to 765 (mean 196) and 7 to 666(mean 132) 
minutes, respectively. To achieve similar results, the performance and the stability of 
the spectrometer needed to be optimal at the beginning of observations.
The sensitivity of a photomultiplier tube (PMT) to NIR light is temperature dependent, 
especially near the long wavelength region. The light level received by a PMT is also a 
strong function of optode spacing and tissue type. To allow for a wide range of 
intensities and to ensure the optimum working temperature is achieved, a settling period 
maybe required for the PMT gain to be optimised at the beginning of fetal 
measurement.
Furthermore, the signal to noise ratio may have an influence on the performance of a 
near infrared spectrometer. Peebles (1993) and Aldrich (1994) found that this was 
particularly the case when monitoring fetuses with thick, black curly hair.
This study therefore set out to define the time required to ensure optimal performance of 
the new PMT in the spectrometer and once signal stabilisation had occurred, to define 
the background signal-noise characteristics of the attenuation, phase and modulation 
depth.
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3.2.2 Methods
The fetal probe, which is described in detail in chapter 4, was applied to a solid conical 
epoxy resin phantom. This phantom was used as it was initially constructed by 
Firbank(1995) to replicate the absorbing properties of biological tissue. The probe was 
secured with black adhesive masking tape and the probe and the phantom were covered 
with black cloth. The optical fibres of the probe were connected to the spectrometer and 
data were collected from the time that the lasers and PMT of the spectrometer were 
switched on. To reflect the potential time that data could be collected from human 
fetuses during labour, data were collected up to 900 minutes. Signal stability and noise 
characteristics were monitored using all four lasers. The modulation frequency was set 
at 200Mhz. Data were collected at half-second intervals. After stabilisation had 
occurred, the standard deviations of the signals of attenuation, phase shift and 
modulation depth were calculated to represent the signal noise for a period of 60 
minutes.
3.2.3 Results
Figure 3.4 shows representative data of attenuation, phase and modulation depth data 
collected by the spectrometer at laser wavelength 856nm. This shows that the time 
taken for the signal to stabilise is in the order of approximately 600 minutes (10 hours). 
Similar results were obtained in the other 3 lasers. Figure 3.5 illustrates the noise within 
the attenuation, phase and modulation depth data after this period of stabilisation and 
table 3.2 shows the noise characteristics represented by the standard deviations of the 
data in these figures.
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Figure 3.4 Attenuation, phase and modulation depth data at wavelength 856nm on a 
solid phantom with the fetal probe.
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Table 3.2. Signal noise characteristics at the four laser wavelengths, represented by 
standard deviations of the signals during the total data collection and the time from 670 
to 770 minutes.
856nm 815nm 787nm 741nm
Attenuation (OD) 
SD (total)
SD (670-770 min)
0.0006
0.0004
005
0.01
0.01
0.003
0.006
0.0005
Phase (RADS)
SD (total)
SD (670-770 min)
0.003
0.0009
0.003
0.0003
0.006
0.0002
0.002
0.0009
Modulation depth 
SD (total)
SD (670-770 min)
0.005
0.0002
0.002
0.001
0.004
0.0003
0.002
0.002
3.2.4 Discussion
This study shows that firstly, the time for signal stabilisation is much longer than for the 
conventional NIRS monitors and secondly the magnitude of the signal noise of the 
current spectrometer is similar to previous published results. Using a similar phantom 
model, Duncan (1993) found similar magnitudes of noise in all three signals 
(0.00060D, 0.0011 RAD and 0.0008 for attenuation, phase and modulation depth 
respectively).
Encouragingly, other studies suggest that this background signal noise level may not 
have an effect on the data that was to be collected on fetuses for this thesis.
Kohl (1997) found that a small increase (15%) in the absorption properties of a liquid 
phantom, similar to biological tissue, results in a much larger change in the three signals 
(attenuation of 0.2 OD, phase of 0.8 RADS and modulation depth of 0.2). From these 
changes it was possible to calculate the absolute absorption properties. Watson (1996) 
found a similar magnitude of attenuation change (0.3OD) in one human fetuses during 
labour. It was therefore likely that the signal noise defined in the study described would 
not have a marked effect on the data collected from fetuses.
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STUDY 3 SIGNAL INTERFERENCE
3.3.1 Introduction
As previously described in chapter 2, the conventional NIRS monitors calculate changes 
in haemoglobin concentration from the changes that occur in the attenuation of near 
infrared light. The sensitivity of the PMT of these spectrometers could not be adjusted 
manually during a study and therefore potentially the PMT may not be able to detect 
changes in intensity of light at low light levels. The commonest reason for failure to 
acquire a good quality signal with these monitors was the inability to transmit sufficient 
light through the tissue. This was observed most frequently if there was a combination 
of thick black curly hair and dark skin (Peebles 1993, Aldrich 1994). Melanin 
significantly reduces the amount of near infrared light transmitted through tissue 
because of its high attenuation. Tissue with a high melanin content, such as black skin 
or hair will therefore effectively screen out transmitted light.
Conversely, the sensitivity of the PMT of the IMOS system used in this thesis could be 
manually adjusted and therefore potentially has the ability to overcome this problem by 
being able to detect changes in attenuation, phase and modulation depth at a far greater 
range of intensities. These measurements are theoretically all independent of each other, 
throughout a range of light intensities and the signal/noise ratio of the phase and 
modulation depth should remain stable and not be affected at extreme ranges of light 
intensities.
This study set out to detect the presence of signal interference (cross-talk) between the 
three parameters throughout a range of intensities that may be encountered during 
studies on human fetuses.
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3.3.2 Methods
A circular disk, whose thickness and thus it’s attenuation properties varied continuously 
as a function of angle, was placed between an optical fibre attached to the spectrometer 
and an optode attached to a solid conical epoxy resin phantom. The spacing distance 
between the incident NIR light on the phantom and the detector optode was set to 3.0 
cm. The whole of the set-up was covered in dark cloth to exclude as much ambient light 
as possible that could otherwise damage the PMT of the spectrometer. The circular disc 
was rotated smoothly through its central axis manually, so that light passing through it 
was increasingly attenuated. Figure 3.6 illustrates the experimental set-up.
Collimating
lens
Rotation o f  disc
Phantom
material Source o f  
NIR light
From IMOS 
output
Circular
disc
Detector
Figure 3.6. Experimental set-up of the signal interference study
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3.3.3 Results
Figure 3.7 illustrates the effect of varying the intensity of detected light on the data 
collected by IMOS at the four laser wavelengths. This shows that as the light signal is 
increasingly attenuated (lower intensity of light reaching the PMT), the phase and 
modulation depth data become affected (cross-talk) and the signal/noise ratio decreases.
3.3.4 Discussion
Ideally the IMOS system should be capable of measuring a wide range of absolute 
concentrations of Hb and Hb02 from fetuses over a wide range of light intensities. 
However, data from the third study suggest that at low intensity detected by IMOS there 
is increasing interference between the three signals. This may have importance therefore 
when the system is applied to fetuses, as wide range of changes in cerebral blood 
volume during intrapartum manoeuvres may not be detected. Unfortunately, the actual 
magnitude of change is currently unknown. Certainly, in neonates with brain injury 
secondary to hypoxia-ischaemia, CBV was found to be higher than in those with normal 
brains (Wyatt 1990), by a factor of approximately 50% (3.00+1.04 and 2.22+0.4 
mls/lOOg of brain tissue, respectively). It is unknown whether changes in fetal cerebral 
blood volume could cause the same change in intensity (2 ODs) which would induce 
signal interference. What may be reassuring, however is that changes in the intensity of 
this order have not yet been encountered during intrapartum monitoring with 
conventional NIRS or with IMOS during the preliminary studies
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phase and modulation depth data (cross-talk).
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3.4 CONCLUSION
These optical phantom studies provide useful information in order to optimise the 
process of data collection during subsequent intrapartum studies. Despite the 
spectrometer being a prototype, the data from study 1 suggest the error of its 
measurements may be as little as 3%. This compares favourably with reported errors of 
conventional NIRS (Elwell 1995), pulse oximetry (Dassell997) and fetal ECG (van- 
Wijngaarden 1996). Due to the long period of initialisation suggested by study 2 and to 
overcome the potential signal interference suggested by study 3, plans were made to 
keep the spectrometer on the delivery suite with the lasers switched. A device to enable 
manual change of the PMT, and therefore reducing the effect of signal interference, was 
to be employed.
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CHAPTER 4
EXPERIENCE WITH IMOS ON DELIVERY SUITE
This chapter describes my experience on the delivery suite at University College 
London Hospital using the intensity modulated optical spectrometer described in section
2.4.4 and a specially designed fetal probe. A summary of this experience is presented, 
the fetal probe is described and details of the observations obtained from fetuses during 
labour are discussed. Table 4.1 provides a summary of the outcome of these studies.
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Table 4.1 Summary of my experience using the spectrometer and fetal probe on 
delivery suite at UCL.
No of women approached 63
No(%) of women consented 49 (78)
No of fetuses to which the probe was not applied 20
-Reasons
-Probe in use 10
-Technical malfunction 5
-Patient request 5
No of fetuses to which the probe was applied 29
Failure in data collection 11
Timing mechanism 3
No light source 3
PMT failure 5
No of fetuses in which data was collected 18
Total time (minutes(range)) 2280(16-440)
No of uterine contractions 97
No of fetuses(contractions) with absolute Hb calculated 10 (60)
4.1 THE FETAL PROBE
The design of the fetal probe was based on those used previously for NIRS intrapartum 
fetal monitoring at UCL by Peebles and Aldrich as they were simple to use, effective 
and not associated with any significant tissue trauma (Peebles et al. 1992).
The probe was designed within the Department of Medical Physics, UCL and 
manufactured by a commercial company (Gorritt pic, Wales). The probe incorporates 
glass prisms that are the ends (optodes) of the fibreoptic bundles (external diameter
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5mm, length 3m) and suction tubing (3mm diameter). A transmitting optode reflects the 
light through 90 degrees to pass through fetal head and the light emerging from the head 
is returned to the PMT in the spectrometer via the receiving optode. The spacing 
between the optodes was 3.5 cm (see figure 4.1). The four optical fibres that conveyed 
the light are encased in Kevlar, which in turn was encased in polvinylchloride tubing. 
This was encased in a heat-shrink sleeve in order to reduce the effect of background 
light and this sleeve terminated 10 cm from the fetal end of the probe to allow flexibility 
during application to the fetal head.
4.2 PATIENT CONSENT
Women were approached on the delivery suite at UCL, both before and during 
established labour, after discussion with their midwife and the medical team on duty. If 
the woman and her fetus were considered suitable for study, the parents were given 
additional written and verbal information about the research project. Consent was only 
sought from mothers who were considered capable of understanding the given 
explanation and preferably only in the presence of her partner and midwife. This was 
obtained from each woman prior to commencement of the study using a specially 
prepared consent form (see appendix 3), which had been approved by the local 
committee on the ethics of human research at University College London.
82
a)
b)
Figure 4.1 a) The optodes (shown by arrows) held at fixed separation from one another 
(3.5cm) in a silicon rubber suction cup and b) the fetal probe in profile.
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4.3 STATISTICS
In order to define the proposed normal ranges for absolute values of haemoglobin it was 
thought necessary to study fetuses from singleton, term pregnancies with cephalic 
presentation and spontaneous onset of labour, leading to normal vaginal delivery 
without the need for oxytocin augmentation or evidence of fetal distress.
With a normal vaginal delivery rate of at University College, London of 65% and an 
augmentation rate of 15% it was estimated that the entry criteria would be met in 
approximately 50% of this group by the end of labour. On the basis of previous 
experience with NIRS, it was anticipated that data from 50 successful studies would be 
required to establish normative values. It was therefore intended to study 100 women 
who were admitted to the labour ward over the course of two years.
Furthermore, it has been previously discussed in section 2.2.2 that many normal 
obstetric practices are associated with a transient fall in cerebral oxygenation. On this 
basis it was anticipated that approximately 25% of the fetuses enrolled in the normal 
group would experience at least one episode during a study.
Power calculations based on previous data suggest that in order to detect changes in 
total haemoglobin concentration occurring during intermittent fetal hypoxaemia, with a 
power of 80% and at a 0.05 significance level, 60 fetuses would be needed to be 
studied.
It was therefore proposed to study a further 50 labours where the fetus was thought, on 
clinical grounds, to be at increased risk of intrapartum hypoxia. These therefore would 
include pregnancies complicated antenatally by intrauterine growth restriction, 
oligohydramnios, antepartum haemorrhage and diabetes and those with intrapartum 
complication such as meconium staining of the liquor and/or an abnormal tochograph.
Due to technical delays with fetal probe and the spectrometer (see chapter 7) there was a 
total of eight months available in which potential intrapartum fetal observations could 
occur.
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4.4 FETAL AND MATERNAL OBSERVATIONS
Despite this, during these eight months sixty-three women were approached to take part 
in the study. Of these, forty-nine women agreed and gave written informed consent to 
the study. The recruitment rate was therefore approaching 80%.
The reasons given from the women who declined to take part in the study were that they 
requested minimal medical interference, others requested water births, while other 
women thought that the probe would restrict maternal movement. These reasons for 
failing to recruit women are similar to those previously described by Peebles and 
Aldrich.
The majority of women approached were Caucasian women as difficulties in obtaining 
consent from women from ethnic minorities were encountered due to communication 
difficulties and cultural differences. Similarly, from previous experience with NIRS 
monitoring women who were primiparous and who had an epidural anaesthesia were 
studied. These groups of women were of particular interest as potentially they provided 
more satisfactory data over a longer period of time
Of the forty-nine women who agreed to take part in the study, twenty of the fetuses 
were not studied due to a failure of labour induction, failure of the membranes to 
rupture, withdrawal from the study during labour or the probe was in use on another 
fetus.
For those women who agreed to take part in the study, it was necessary for the 
membranes to have ruptured before the probe could be applied. Artificial rupture of the 
membranes was only performed where clinically indicated, not in order to commence 
measurements. The probe was applied only during routine vaginal examinations by JC 
and was inserted through the dilated cervix (minimum 2-3 cm) after rupture of the 
amniotic membranes. This occurred either spontaneously or following artificial rupture 
for clinical indications. The probe was introduced between the fetal head and cervix and 
applied against the fetal head and maintained in position by both maternal tissue
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pressure (from either lower uterine segment, cervix or vagina) and controlled 
continuous negative pressure (150 mmHg), provided by the wall suction apparatus.
Once the probe was applied, the optical fibres were connected to the laser output of the 
spectrometer. A Hewlett Packard CTG monitor was connected to the spectrometer via 
the external analogue channels and suction tubing was connected to the fetal probe.
Data collection was commenced from the time the lasers and the PMT of the 
spectrometer were switched on by DK. Data were collected at 0.5 second intervals and 
the computer screen displayed the number of photons being back-scattered to the PMT 
for all four lasers and the elapsed time in seconds (see figure 2.2). JC or DK recorded 
events during labour in logbooks with the corresponding elapsed time.
If there was sufficient light being detected by the spectrometer, as assessed by the 
number of photons detected displayed on the computer screen data collection continued. 
If there was too much light being detected, the voltage of the PMT was reduced to avoid 
oversaturation and possible damage to the PMT. If there was no data being recorded due 
to technical difficulties with the lasers or PMT, the study was abandoned.
Subsequent vaginal examinations, during data collection, were performed by JC. The 
probe position was checked at each vaginal examination, which occurred every two to 
four hours. Where feasible, observations were continued until the point of delivery. 
After completion of a study the raw data obtained was saved on the hard drive of the 
computer system in the spectrometer along with the CTG data. At the end of the study, 
the raw data were averaged over 5 seconds intervals and saved on to a 3 1/2-inch floppy 
disc for subsequent analysis.
On completion of a study, the probe was washed thoroughly in hot water and 
chlorhexidine 0.1 % solution to remove all organic material, and then sterilised in 
gluteraldehyde solution for 10 hours within the Medical Physics Department. It was 
rinsed with sterile water, before being repackaged in a sterile drape. This method for 
disinfecting the probe was approved by the Department of Microbiology at University 
College, London.
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Of the forty-nine women who gave written consent, the probe was applied to the head 
of twenty-nine fetuses during the first and second stage of labour (see table 4.2). As 
previously mentioned the probe was either in use on another fetus or more commonly 
the spectrometer malfunctioned before the probe could be applied which preventing 
data being collected in twenty of the women.
Of the 29 fetuses in which the probe was applied, it was not possible to collect data in 
eleven of these. This was due to unpredictable intermittent technical problems with the 
spectrometer. Initially this was due to failure of the timing mechanism (n=3) and then in 
subsequent studies it was due to the spectrometer failing to generate a light source (n=3) 
and failure of the PMT (n=5).
In eighteen of the twenty-nine fetuses, the individual components of the spectrometer 
functioned properly and data was collected that could be used for subsequent analysis.
Continuous observations in these eighteen fetuses were obtained for periods lasting 
from 16 to 440 minutes (mean 127) with a total number of hours of 38. The details of 
these 18 studies are given in table 4.2.
The probe was applied to the fetal head when the cervix was as little as 3cm dilated. It 
was then possible to collect data for long periods, extending through the first stage of 
labour, although due to the inflexibility of the probe, occasionally it would detach 
during a maternal movement. In two fetuses monitoring was continued through to the 
point of delivery. None of the mothers found that the actual process of optical 
monitoring was uncomfortable. Although the technique did not interfere with routine 
clinical management, the majority of women, their partners, and the attending medical 
and midwifery staff commented on the space taken up in the delivery room by the 
spectrometer, DK and JC during a study (see figure 4.2).
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Table 4.2. Maternal details and outcome of labour in the 18 studies from which data 
was collected.
Study details No.
No of women Primigravida 11
Multiparas 7
Race Caucasian 15
Afro-Caribbean 3
Gestation (weeks) Mean(S.D.) 39.7 (+/-1.0)
Analgesia Epidural 10
Entonox/pethidine 8
Labour Spontaneous onset 14
Induction 4
Mode of delivery NVD 10
Instrumental 4
LSCS 4
Indication for operative delivery
Distress 1
Failure to progress 7
Umbilical pH < 7.2 2
Apgar <7 (1 min) 2
Apgar <7 (5 min) 0
Cervical dilatation at application 3-5 cm 7
6-9 cm 9
10 cm 1
There were no intrapartum or postpartum complications related to probe insertion in any 
of the mothers and no fetal injuries or infections were observed. Only one fetus required 
an emergency Caesarean section for fetal distress, following an ante-partum
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haemorrhage in the first stage of labour. Although the fetus required resuscitation at 
birth, there was no development of hypoxia-ischaemic encephalopathy.
In the 18 fetuses there were contraction-related changes in light attenuation data, which 
allowed calculation of changes in Hb and HbC>2 . Of these 18 fetuses, there were 
contraction-related changes in phase shift and modulation depth in 10 of these and 
therefore the Mathematica™ notebook (see chapter 7) could calculate absolute 
measurements of Hb and Hb02. In the other eight fetuses the signal/noise ratio in the 
phase and modulation depth data was too low. This was thought to be because 
insufficient light was detected arising from either the presence of dark curly hair under 
the probe. Melanin significantly reduces the amount of near infrared light transmitted 
through tissue because of it’s high attenuation. Tissue with a high melanin content, such 
as black skin or hair will therefore effectively screen out transmitted light. It is likely 
that this was the explanation for the noisy signal obtained from these fetuses, although it 
is not known in how many successful cases black hair was also present. This was also 
the reason given for failing to obtain a signal using conventional NIRS (Peebles 1993). 
Occasionally this problem was overcome by practical measures such as sweeping the 
hair aside, by moving the optodes across the fetal scalp, or positioning them over an 
area with less hair. If data was not obtained after a maximum of two attempts at 
positioning the probe, the study was abandoned.
The maternal and labour details of the 10 fetuses are shown in Table 4.3. There were no 
fetal blood samples performed during observations. In all ten fetuses, the cord pHs were 
above 7.2 and there were no admissions to the neonatal intensive care unit.
Data were obtained during a total number of 97 uterine contractions with related 
changes in the three signals. Of these, 60 contractions the Mathematica programme 
calculated absolute absorption coefficients within the range of biological tissue at more 
than one laser wavelength which used to calculate measurements of absolute 
concentrations of Hb and Hb02.
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Table 4.3. Details of labour and delivery in the 10 fetuses in which contraction related 
data in phase, modulation depth were obtained
Maternal age 34 (22-42)
Gestation 39 (37-41).
Race
Caucasian 9
Afro-Caribbean 1
Parity
Primiparous 7
Multiparous 3
Onset of labour
Spontaneous 9
Induced 1
Epidural 5
Mode of delivery
Normal vaginal 5
Instrumental 2
Caesarean 3
Cord pH < 7.2 0
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Figure 4.2 Photograph to illustrate the dimensions of the spectrometer with JC and DK.
91
4.5 DISCUSSION
The total number of fetuses studied and the number in which satisfactory data were 
collected using IMOS were relatively small, compared with previous experience at UCL 
using commercially available NIRS monitors.
Peebles designed and manufactured a fetal probe and applied this to 40 fetuses. Peebles, 
using a similar probe to the one used in this study, investigated fetuses with a success 
rate of approximately 75% (Peebles 1993). Following on from Peebles, Aldrich studied 
a total of 75 fetuses and obtained satisfactory data in 68 (90%) fetuses (Aldrich 1994c). 
Watson et al (1996) studied the changes in the optical pathlength during uterine 
contractions with IMOS. Data was satisfactory for analysis in four of the 10 fetuses 
studied. Insufficient light detected has been cited as the main reason for obtaining poor 
quality data with NIR intrapartum monitoring and is usually due to the presence of thick 
black hair and skin underneath the probe.
In this study the recruitment rate was relatively high and primiparous Caucasian women 
were particularly targeted to in an attempt to prolong the period of observation and 
reduce the problem of black hair. However technical problems with the spectrometer 
and probe reduced the number of satisfactory fetal studies. These problems reflected the 
fragility of the individual components of the instruments. Usually, these problems were 
not resolvable at the time of the study and therefore the studies were abandoned.
Despite these practical problems, overall raw data were obtained during labour with 
IMOS in approximately 62% of women studied and of these, 55% provided data 
suitable for analysis.
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CHAPTER 5
INTRAPARTUM MEASUREMENT OF FETAL CEREBRAL HAEMOGLOBIN 
CONCENTRATION AND OXYGEN SATURATION WITH IMOS.
INTRODUCTION
As discussed in chapter 1, direct information on cerebral haemodynamics during uterine 
contractions (Peebles 1992a), fetal heart rate decelerations (Aldrich 1995a) and obstetric 
manoeuvres (Aldrich 1994b) have been reported using the conventional NIRS 
monitoring system at UCL.
However, interpretation of the results is hampered by the fact that the technique used to 
date provides information about changes in the concentration of Hb02 and Hb 
calculated from an arbitrary baseline set at the beginning of the study. Thus it is only 
possible to obtain relative rather than absolute quantification of total haemoglobin and 
therefore cerebral blood volume.
A method has been described for measurement of cerebral saturation (Peebles 1992), 
but this relies on parallel changes in HbC>2 and Hb, which do not always occur. This 
problem reduces the clinical value of NIRS as it is not currently possible to quantify 
cerebral blood volume, and therefore the degree of cerebral vasodilatation, at the 
beginning of the study. On the basis that the initial fetal response to acute hypoxia is 
cerebral vasodilatation and an increase in cerebral blood flow, knowledge of absolute 
blood volume might help distinguish the normoxic from the hypoxic fetus.
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This chapter therefore describes the studies undertaken using IMOS to define normal 
values for fetal cerebral total haemoglobin concentration (HbT) and mean cerebral 
oxygen saturation (Smc0 2 ) during the first stage of labour.
5.1 METHODS
Twenty-nine pregnant women were recruited into the study during uncomplicated 
labour at term, the details of which are described in chapter 4. All had a singleton 
cephalic presentation and were studied after either spontaneous or artificial rupture of 
membranes.
During routine vaginal examination the silicon rubber probe, especially designed to 
hold two optic fibre bundles at a constant separation of 3.5cm, was inserted through the 
cervix after 3cm dilatation and placed against the side of the fetal head.
This separation was used as it was the maximum size possible because of the sheathing 
and the prism size and Peebles (1993) found this to be the optimal distance for obtaining 
fetal data.
The standard, unmodified wall suction apparatus provided controlled, continuous 
negative pressure (150 mmHg below atmospheric) to maintain contact between the 
probe and the head. This level of suction was used to maintain good probe apposition 
was similar to that used in other studies (Peebles 1993, Aldrich 1994c) where no 
evidence of fetal trauma was observed. The fetal heart rate and uterine contractions 
were monitored continuously using a cardiotocograph (Hewlett Packard 80300A, 
Hewlett Packard, Massachusetts, USA).
Off-line evaluation of the raw IMOS data was performed using the Mathematica™ 
notebook. This produced changes in Attenuation, phase and modulation depth at the 
four different wavelengths.
First, changes in light attenuation during the course of a study were used to calculate 
changes in cerebral Hb and Hb02 concentration using a similar method to those 
previously described (Peebles 1992).
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In addition, the novel analytic method was used to quantify absolute tissue absorption 
coefficients from the ratio of any two of the changes in A,P, and M. These were then be 
used to calculate absolute haemoglobin concentrations (pmol/1).
Data were analysed from the first three uterine contractions for each fetus that fulfilled 
the following criteria: a) tocographic evidence of uterine activity associated with 
changes in optical parameters, b) occurring during the first stage of labour, c) a normal 
FHR pattern d) and no gross change in maternal posture, and e) no maternal oxygen 
therapy or drug administration.
Summing of Hb and HbC>2 provides the total haemoglobin concentration (HbT in 
umol/1), and the ratio of HbCV HbT provides the cerebral saturation (SmcC^) expressed 
as a percentage (%).
Statistical analysis was performed on commercially available software (Sigmaplot V4.0. 
SPSS Inc. 1997).
An estimate of Cerebral Blood Volume (mls/lOOg) was derived using the following 
equation:
CBV = HbT x MWHbXlO-6/ tHb x 10'2 x D, x 10 
where MWnb is the molecular weight of haemoglobin (64500), tHb is the mean 
umbilical vein Hb concentration (16.8g/dl) (Wintrobe 1997) and Dt is the brain tissue 
density (1.05g/ml).
RESULTS
Figures 5.1 and 5.2 illustrate the method of deriving absolute concentrations of Hb and 
HbC>2 from the contraction-related attenuation and phase data using the Mathematica™ 
programme. Figure 5.1 shows typical changes, from one fetus, in attenuation and phase 
shift during a contraction. If change in attenuation at one wavelength (856nm), 
measured between the start and peak of a uterine contraction, is plotted against a
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corresponding change in phase shift (shown in Figure 5.2), the gradient of the first order 
regression line (Q, 7.84 OD/RAD) can be calculated, giving an absolute absorption 
coefficient (pa) of 0.018 mm'1. Using the same method, the absolute pa calculated at 
wavelength 787nm was 0.016 mm'1. Using these calculated absolute pas it was possible 
to calculate absolute concentrations of Hb and HbC>2 , using previously measured 
extinction coefficients for Hb and HbC>2 , and these were 42 and 26 pmol/1 respectively.
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Figure 5.1 Changes in attenuation and phase at 841nm over one uterine contraction in a 
fetal study.
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Figure 5.2 Scatter plot and first order regression line obtained from the changes in 
attenuation and phase during the start (point a) and peak of the contraction (point b) in 
fig 5.1.
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Figure 5.3. Absolute concentrations of cerebral Hb (open circles), HbC>2 (closed circles) 
and HbT (closed triangles) (umol/1), and cerebral saturation, calculated over 3 uterine 
contractions in the same fetus are shown in Figure 5.1 and 5.2.
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Absolute concentrations of Hb and HbC>2 were obtained during the up- and down-slopes 
during three consecutive contractions (see Figure 5.3). These gave a mean value of 
absolute concentrations of cerebral Hb and HbC>2 of 40 +/-4pmol/l and 28 +/-4 (mean + 
SD) respectively, giving a mean absolute total haemoglobin of 68 +/-3 pmol/1 and 
SmC02 of 41 +1-5%.
Using the same methods on the data from the 10 fetuses, the mean +/-SD absolute 
concentration of Hb and HbC>2 calculated were 30 +/-18 and 46 +/-21 pmol/1, 
respectively. This gave a mean cerebral HbT of 77 +1-29 pmol/1 and a mean Smc02 of 
59 +/-12 %. Assuming a large vessel mean haemoglobin concentration for the term 
fetus of 16.8g/dl the calculated mean HbT concentration equates to a mean fetal cerebral 
blood volume of 2.8 +/-1.0 mis / lOOg.
Table 5.1 Data from the individual fetuses (n=10).
Study Hb02 Hb HbT SmcC>2
(pmol/1) (pmol/1) (pmol/1) (%)
1 28 (4) 40 (4) 68 (3) 41 (5)
2 74(14) 29(13) 103 (25) 73 (7)
3 42(16) 31(11) 73 (26) 57(5)
4 88(42) 53 (24) 141(48) 62(16)
5 52 (26) 13(12) 65 (35) 81 (10)
6 29(16) 27 (8) 56(18) 49(16)
7 47 (21) 45 (37) 93 (56) 57 (23)
8 37 (23) 30 (29) 67(49) 58(19)
9 19(6) 18(11) 37(5) 53 (23)
10 44 (22) 22(12) 66 (31) 67 (7)
Data are expressed as mean +/-1SD. HbC>2 = oxyhaemoglobin. Hb = deoxyhaemoglobin 
HbT = total haemoglobin. SmCC>2 = saturation.
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In four fetuses it was possible to calculate SmcC>2 over these uterine contractions using 
the conventional method of analysis, as there were parallel changes in Hb02 and HbT. 
This gave a calculated mean Smc02 of 58 +/-19%. In these four fetuses the mean 
SmcC>2 was 59 +/- 17 % calculated by the novel IMOS analytic method (p = 0.84). 
Figure 5.4 shows that if absolute measurements of Hb, HbC>2 and HbT concentration are 
used as a starting point on the continuous data collected by the conventional NIRS 
method (which starts at arbitrary baseline), absolute measurements of Hb, HbC>2 , HbT 
and cerebral saturation can be represented in a continuous fashion.
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time ( 8 mins)
Figure 5.4 Measurements of absolute concentrations of Hb, HbC>2 , HbT (pmol/1) and 
cerebral saturation (%) by IMOS (a) using the novel method of analysis (dots) and (b) 
using an absolute measurement on the changes in Hb, HbC>2 , HbT to provide continuous 
absolute measurements (line), over 3 contractions from a fetus during labour.
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5.3 Measurements during obstetric events
5.3.1 Early deceleration
Of the 10 fetuses that were analysed during the first stage of labour, nine were identified 
as having a ‘normal’ cardiotocograph in that they were not associated with a significant 
change in the fetal heart rate (FHR). The remaining fetus had 6 uterine contractions that 
were associated with early FHR decelerations. Absolute Hb, Hb02 and HbT were 
determined for each uterine contraction during the FHR deceleration and during the 
preceding and subsequent contraction (see figure 5.5). When the uterine contractions 
were associated with early FHR decelerations, the mean (S.D.) absolute cerebral Hb02 
fell by 5 (+/- 0.3) fimol/1 and absolute Hb rose by 8 (+/- 0.2) (imol/1. Absolute HbT rose 
by 3pmol/l (+/- 0.3). These results indicate that there was a transient desaturation of the 
blood within the fetal brain, which occurred simultaneously with the deceleration in 
FHR. This is confirmed as there was a fall in cerebral saturation of 8% (+/-0.5%).
5.3.2 Fetal bradycardia
In one fetus, it was possible to obtain measurements during a fetal bradycardia 
secondary to an antepartum haemorrhage (APH) (see fig 5.6). During the fetal 
bradycardia, absolute HbC>2 fell consistently from 27pmol/l to 9pmol/l. There was an 
initial fall in absolute Hb from 15umol/l to 12umol/l and then a subsequent rise up to 
24pmol/l. Absolute HbT calculated from the sum of HbC>2 and Hb fell from 42pmol/l to 
27pmol/l and then rose to 33pmo 1/1. This corresponded to a fall in CBV from 1.5 to 
0.98 mls/lOOg then a rise to 1.2 mls/lOOg. Absolute cerebral saturation was initially 
maintained at 63 and 56% but then dramatically fell to 25%. These data are consistent 
with an impairment in placental function secondary to the APH. The secondary rise in 
HbT (and therefore CBV) may be due to impairment in cerebral venous drainage, but it 
is more likely to be due to vasodilatation of the cerebral vasculature, in an attempt to 
maintain cerebral blood volume. This suggests that the fetus studied had adequate 
amount of reserves to avoid the permanent sequelae of ischaemia, in response to 
increasing fetal hypoxia. The fetus was delivered by emergency caesarean section and 
although it was bom with Apgar scores of 3 at 1 minute and 5 at 8 minutes and the
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umbilical artery cord pH was 7.19, after resuscitative measures, the neonate did not 
require SCBU admission and there was no short or long term neurological deficit.
5.3.3 Effects of delivery
In one fetus it was possible to continue observations on the brain throughout the process 
of delivery and the initiation of spontaneous respirations. Figure 5.7 shows the changes 
in Hb, HbC>2 and HbT calculated in the conventional manner (from an arbitrary 
baseline) and absolute HbT and cerebral saturation (using absolute measurements of Hb 
and HbC>2 as a starting point). With the onset of respirations, Hb(> 2  rose rapidly by 
6pmol/l and Hb fell byl5pmol/l. Simultaneously HbT fell by 1 lpmol/1 (from 55pmol/l 
to 44pmol/l) corresponding to a fall in CBV of 0.4mls/100g (from 2.0 to 1.6mls/100g) 
and cerebral saturation rose from 72% to 98%. The fetus was bom with normal Apgar 
scores and umbilical cord gases.
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during an early FHR deceleration.
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5.4 Discussion
The data presented in this chapter are the first to describe absolute quantification of 
oxyhaemoglobin and deoxyhaemoglobin concentrations within the brain of the human 
fetus during labour. The techniques described in this study allow absolute quantification 
of cerebral concentrations of total haemoglobin (HbT), by summing Hb and HbC>2 , and 
therefore provide information on fetal cerebral blood volume (CBV) as HbT is related 
to CBV.
In the absence of any published fetal values the most relevant values with which to 
compare the CBV measurements reported here are those obtained in the human neonate 
shortly after birth (Wyatt 1990). These were calculated using parallel changes in 
peripheral oxygen saturation, measured by pulse oximetry, and cerebral haemoglobin 
concentration, measured by NIRS, in response to an alteration in the inspired oxygen 
fraction in ventilated neonates. In neonates with brain injury secondary to hypoxia- 
ischaemia, cerebral blood volume was found to be higher than in those with normal 
brains (3.00+1.04 and 2.22+0.4 mls/lOOg of brain tissue, respectively). The value 
calculated during the first stage of labour in this study is closer to that seen in neonates 
post hypoxia-ischaemia than in those with normal brains and suggests that normal fetal 
values may be higher than normal neonatal values.
There are several possible explanations for a raised CBV during the first stage of labour. 
Mean fetal PO2 is known to fall during normal labour and baseline fetal levels are lower 
than those in the neonate. In animal studies hypoxia leads to a redistribution of cardiac 
output with an increase in adrenal, cardiac and cerebral blood flow and a fall in blood 
flow to carcass muscle, gut and kidneys. Similar changes have been noted in the human 
fetus during labour with an increase in middle cerebral artery blood flow, measured by 
Doppler, in fetuses with a low peripheral oxygen saturation (<30%) measured by pulse 
oximetry (Sutterlin 1999).
Another mechanism that could increase CBV during labour is hypercapnia, a potent 
vasodilator of the cerebral circulation and a decrease in venous return to the heart 
because of thoracic compression during uterine contractions.
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The observations during delivery indicate the magnitude and rapidity of the changes in 
cerebral oxygenation and perfusion during delivery. These changes indicate a rapid rise 
in cerebral oxygenation, reflecting the rise in arterial saturation. A fall in CBV of 0.4 
mls/lOOg is approximately 20% if the previously published mean value of 2.22 ml/lOOg 
for normal neonates is used (Wyatt 1990). There are several reasons why this may 
occur. A change in thoracic pressure could cause blood to withdrawn from the 
extremities, including the brain, and therefore a fall in CBV. This effect would probably 
occur rapidly, during the first few seconds after delivery. A more gradual change may 
occur as the result of changing blood gases. Both hypoxia and hypercapnia are potent 
vasodilators of the cerebral circulation. The data presented here show that show that 
cerebral saturation increases rapidly after birth and it is reasonable to suppose that 
PaCC>2 will fall with the onset of respiration. These changes will lead to 
vasoconstriction and a fall in CBV.
The ability to quantify the cerebral concentrations of HbC>2 and Hb using these 
techniques also make it possible to calculate cerebral oxygen saturation. Previous 
studies using NIRS have described values for Smc02, calculated by defining the 
fraction of a measured change in HbT due to a change in HbC>2 . This assumes no change 
in oxygen saturation during measurements and requires that both Hb and HbC>2 change 
in parallel. As these conditions are not always met the use of this technique is limited. 
Given values ranged between 43 and 47% (Peebles 1992b, Aldrich 1994a). Although 
these are slightly lower than the mean value given here, obtained by IMOS, the standard 
errors are large. In the four fetuses in which it was possible to use both methods of 
measuring Smc02 there was almost complete agreement between values. It should be 
repeated that the saturation values given are for haemoglobin within all three vascular 
compartments and so should lie between expected arterial and venous values. Certainly 
they are higher than mean arteriolar saturation measured by pulse oximetry which is
42.2 % (Goffinet 1997).
The transient fall in cerebral saturation in response to FHR decelerations is consistent 
previously published data (Peebles 1992) using conventional NIRS that are described in 
section 2.2.2.1. Similarly, the changes that occurred in cerebral oxygenation and
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perfusion in response to a fetal bradycardia are consistent with data during inadvertent 
hyperstimulation of the uterus with oxytocin (Peebles 1991). In both of these cases it the 
IMOS system allowed calculation of absolute oxy- and deoxyhaemoglobin from which 
absolute changes in cerebral saturation and CBV were derived.
There is a wide variation in the observed values in the 10 fetuses as shown in table 5.1. 
It is possible that this reflects the complexities that occur within the different vascular 
compartments within the fetal brain during labour that potentially could have an effect 
on the sensitivity of the IMOS system and analytic process. Watson (1996) has also 
reported the sensitive nature of IMOS during fetal studies.
These data suggest that IMOS has the potential to provide the first continuous 
measurements of both fetal cerebral blood volume and saturation during labour. Of the 
two parameters it is likely that changes in CBV, which reflects vascular tone, will be the 
best predictor of potential neurological damage occurring due to intrapartum hypoxia. 
As mentioned previously, hypoxia is associated with cerebral vasodilatation in both 
human and animal studies, which leads to an increase in both cerebral blood flow and 
volume. It is thought that this is a compensatory mechanism that maintains cerebral 
oxygen and substrate delivery. It is only during severe oxygen deprivation that cerebral 
perfusion falls (Bennett 1998), endogenous protective mechanisms are overwhelmed 
and brain injury ensues. Certainly, in the ovine fetus the severity of brain injury 
correlates better with the degree of hypotension and cerebral hypoperfusion than 
oxygenation (Gunn 1992). This may be why intrapartum pulse oximetry, which 
measures peripheral arteriolar saturation, but provides no direct information on cerebral 
perfusion, has yet to show a beneficial effect on either the rate of obstetric intervention 
or neurological outcome. Similarly, the clinical use of fetal ECG waveform analysis, 
which provides no direct information on cerebral oxygenation or perfusion, may be 
limited (Strachan 2000). In contrast the data presented here suggest that using IMOS it 
may be possible to assess both the degree of fetal cerebral hypoxia and, more 
importantly, the haemodynamic response to it.
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CHAPTER 6
THE CONTRIBUTION OF ARTEFACT TO NIRS MEASUREMENTS. 
INTRODUCTION
Having obtained data from a dead fetus during labour using a conventional NIRS 
monitor and a transparent fetal probe which relied on pressure from maternal tissue 
alone, Hamilton (1995) was able to reproduce similar results to Peebles (1992b). This 
data questioned the validity of conventional NIRS measurements. Of a total of 70 
contractions that were suitable for analysis, they found that in 28 there were similar 
changes in Hb02 and Hb that had previously been described in viable fetuses (Peebles 
1992) and illustrated in chapter 2 of this thesis. From these changes it was possible to 
calculate a mean cerebral saturation of 71.9%. Hamilton argued that because there was 
no possibility of a change in cerebral oxygenation in a dead fetus, the apparent 
concentration changes recorded by the NIRS monitor were likely to be a result of 
changes in the geometry in the fetal probe, which were occurring in direct response to 
the pressure exerted during a uterine contraction.
Theoretically this may be possible. Conventional NIRS monitors (used by Peebles and 
Hamilton) have been programmed such that in the analysis of data, which is based on 
the modification of the Beer-Lambert Law (see chapter 2), the space between the 
optodes (or interoptode spacing (IOS)) and hence the optical pathlength is assumed to 
be constant.
I l l
If there were changes that occurred in the IOS during the uterine contractions, this 
would have led to a change in optical absorption and thus wrongly interpreted as 
changes in chromophore concentration by the conventional NIRS monitors. This could 
theoretically account for some or all of the contraction-related changes in concentration 
of oxy- and deoxyhaemoglobin documented by Peebles.
Although Peebles used optodes that were held securely at a fixed separation from one 
another within a black silicone moulding, the possibility remains that small changes in 
optode position during uterine contractions may alter the interoptode space and hence 
lead to erroneous calculation of changes in fetal cerebral haemoglobin concentrations.
IMOS has the unique ability to provide more information on changes in the optical 
signal compared with the conventional NIRS monitors. This is because in addition to 
measuring attenuation changes, which enables calculation of changes in haemoglobin, 
IMOS measures the changes in phase of the optical signal. If changes in phase are 
measured it is possible to calculate changes in optical pathlength (Ad), which is directly 
related to the IOS. Phase and optical pathlength are inversely related by the following 
equation (Kohl 1996).
Ad= - AOc/27tnvm.
where AO is the change in phase of a lightwave, intensity modulated at a frequency vm 
(200MHz) c is speed of light in a vacuum and n is the refractive index of tissue (1.4)
To replicate biological tissues such as the fetal brain, optical phantoms have been 
developed. A s previously described in chapter 3, these can be designed so that they 
have similar optical properties to biological tissue and changes that occur in the optical 
signal can be manipulated in a controlled manner. It was therefore thought by using a 
specially designed optical phantom, it was possible to provide information on the 
changes that occurred in the optical signal during the previously described fetal studies.
The study in this chapter therefore had two aims (a) to identify changes in the optical 
signal (attenuation and phase), using an optical phantom, in response to controlled
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changes in IOS and chromophore concentration and (b) to compare these to the data 
observed in response to uterine contractions during intrapartum fetal monitoring. It was 
hoped that this would therefore provide information on the contribution of IOS changes, 
and hence ‘artefact’ to near infrared fetal studies.
MATERIAL AND METHODS
To represent the fetal brain, the optical phantom employed in this study consisted of 
Opaque Polyester Pigment Super White 407-220 liquid held within an electronic 
component box (dimensions 114x89x51 mm,). Within this liquid the ends of two 
optical fibres (optodes) were placed 25mm apart just under the surface (Figure 6.1). The 
ends of the optodes were held securely in specially designed vices, whose separation 
could be measured and adjusted manually. The optical fibres were connected to the 
spectrometer.
* T O  PMTFrom
IMOS
Metat-bracket
■Epoxy resin lid
IOS 
=2 5 mm
Figure 6.1 Diagram of the experimental set up to change IOS and absorption coefficient 
in an optical phantom.
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In order to represent changes in chromophore concentration, such as haemoglobin in 
biological tissue, the container had a small hole on its superior aspect, which allowed 
the addition of light- absorbing liquids. The liquid used in this study was Zeneca Pro Jet 
900NP. At two-minute intervals, 10 microlitres of dye were added to the optical 
phantom, via a micropipette to increase the absorption properties of the optical 
phantom. A total of 100 microlitres was added to the phantom.
To represent changes that may occur due to pressure on the fetal probe during uterine 
contractions the distance between the optodes was increased by 10mm over 30 seconds 
(n=ll). This distance was then decreased back to the original starting point. These 
changes in the IOS were made in between the additions of the dye.
The changes in attenuation, phase and modulation depth data were collected by the
TW
spectrometer and analysed using the Mathematica programme previously described in 
chapter 3. These data were then compared with the data collected from the ten fetuses 
described in chapter 5 and data collected during a routine vaginal examination during 
which the position and the application of the fetal probe was checked by JC.
Results
Qualitative
Figure 6.2 shows the effect on the attenuation and phase data of increasing the 
concentration of the dye within the optical phantom and the effect of changing the 
interoptode spacing at wavelength 856nm. Similar effects were found at all laser 
wavelengths.
It can be seen that increasing the concentration of dye resulted in an increase in both 
attenuation and phase (and therefore a decrease in optical pathlength, from equation 
6.1). The small peaks seen are as a result of mixing the dye within the solution. 
Conversely, increasing the IOS resulted in an increase in attenuation and a decrease in 
phase. The changes from increases in concentration are in the same direction as figures,
6.3 and 6.4, which illustrate typical changes in the data, obtained from fetuses during a 
uterine contraction. Figure 6.5 illustrates the changes in attenuation and phase during a
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vaginal examination in which the fetal probe was palpated to check its correct position 
and application. It can be seen that the changes in attenuation and phase are in the same 
direction as the changes that occur during a change in IOS.
Table 6.1 provides a qualitative summary of the data obtained.
Table 6.1 Qualitative representation of the changes in optical parameters during the 
described physical changes.
attenuation phase pathlength
T dye T t 4
concentration
4IOS 4 T 4
uterine T T 4
contraction
Vaginal exam 4 T 4
Quantitative
Table 6.2 shows the mean (+/-S.D.) changes in attenuation, phase and optical pathlength 
calculated during this study and compared with the changes during uterine contractions 
from the 10 fetuses.
Table 6.2 Qualitative representation of the changes in optical parameters during the 
described physical changes.
optical
attenuation Phase pathlength
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(OD) (RADS) (mm)
dye 0.071 (+/-0.028) 0.02 (+/- 0.003) 3.4 (+/-0.05)
concentration
IOS (10mm 1.7 (+/- 0.08) 0.51 (+/-0.04) 85 (+/-0.7)
change)
Uterine 0.49 (+/- 0.027) 0.06 (+/-. 0.002) 10.2 (+/- 0.032)
contraction in
10 fetuses
It can be deduced from the data in table 6.2 that a 1mm increase in IOS would lead to an 
increase in attenuation of 0.17 OD and a mean decrease in phase of 0.051 RADS with a 
corresponding increase in pathlength of 8.5mm. These figures are of the same 
magnitude as those obtained from the fetuses during uterine contractions however the 
pathlength change is in the opposite direction.
Figure 6.6 illustrates what happens if the Mathematica software programmed to 
calculate changes in total haemoglobin concentration, such as the conventional NIRS 
monitors, during the optical phantom study. A mean (+/-SD) increase in HbT of 3.1 (+/- 
0.03) umol/1 during an increase of 10mm in IOS can be calculated from these data, 
(hence 0.31 umol/1 during a 1mm increase in IOS).
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Figure 6.4 Data obtained from a fetus using IMOS showing a decrease in both 
attenuation and phase in response to a uterine contraction.
119
-20
GO -40 -
-60 -
-80 -
-100 -
VE4
Time
(min)
Figure 6.5 Changes in attenuation and phase as a result of a vaginal examination during 
fetal monitoring.
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Figure 6.6 The changes in total haemoglobin calculated by the Mathematica software 
programme for the phantom data.
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DISCUSSION
This chapter describes a study to show that IMOS allows calculation of changes in 
optical pathlength during changes in IOS and changes in chromophore concentration, 
using media with light-absorbing properties similar to biological tissue. IMOS also 
allows the display of the raw data from fetuses, so that assessment of the contribution of 
IOS changes or ‘artefact’ can be made.
These data show that there are different optical pathlength changes, both in magnitude 
and direction, in response to changes in IOS and chromophore concentration. 
Additionally, the data observed during concentration changes are similar to data derived 
from human fetuses in response to uterine contractions during labour.
Although, the tissue-simulating medium used can not completely represent the 
complexities of biological tissue, these data suggest that the observed changes during 
uterine contractions are dominated by chromophore changes and not by IOS changes. 
These data have the potential to describe the argument put forward by Hamilton et al. It 
is clear that optical pathlength during infrared monitoring does change during 
concentration and IOS changes. However, in viable healthy fetuses concentration 
changes dominate the changes observed in attenuation. It is likely that in the non-viable 
fetus studied by Hamilton IOS changes provided the attenuation changes from which 
the conventional NIRS calculated the haemoglobin concentration changes. It can be 
seen from this study that even a 1mm change in IOS resulted in the similar magnitude 
of attenuation change (and calculated haemoglobin) that is similar to that obtained by 
Hamilton (0.4 umol/1.).
It may possible to use the IOS changes that occur during uterine contractions to provide 
measurements of haemoglobin concentration. Kohl et al (1997) have used IOS changes 
to provide measurements of chromophores in tissue-simulating media. However what 
seems to be important in fetal monitoring as previously described in chapter 1 is the 
absolute measurement of cerebral oxygenation. It is of more importance that progressive 
chronic hypoxia during labour is detected rather than the changes that may occur during 
uterine contraction in cerebral oxygenation.
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CHAPTER 7
PRACTICAL PROBLEMS AND FUTURE DEVELOPMENTS
Any direct form of intrapartum fetal monitoring will be affected by limited access, the 
correct placement of the measuring device and the unpredictability of events that occur 
in labour. It may therefore be difficult to collect and analyse data from fetuses during 
the physiological events that occur during the intrapartum period. The problems that 
were encountered with using the spectrometer and probe used in this thesis and with the 
subsequent data analysis will be discussed in this chapter.
7.1 DATA COLLECTION
7.1.1 Optode contact
One of the main reasons for failing to acquire data was poor contact between the 
optodes and the fetal scalp. Any fetal device applied to the fetal head suffers from blind 
insertion, limited access, and maternal movement affecting the measuring device. 
Hence, loss of optode contact could occur at any time during a study. Part or the entire 
probe may become dislodged and this was most frequently observed with rapid descent 
and/or rotation of the fetal head (especially at the end of the second stage of labour), 
during difficult vaginal examinations and with rapid changes in maternal position. 
However, this was sometimes easily recognised by either a break in the suction 
apparatus (accompanied by amniotic fluid in the tubing) or the display on the 
spectrometer suggested that too much light was reaching the PMT and oversaturating it. 
Occasionally the probe became detached completely during a vaginal examination and 
the probe was simply reapplied. An example of the effect of this on the data is shown in 
figure 7.1. Large changes in maternal posture especially if they were not predicted were 
associated with the probe dislodging. The weight and inflexibility of the material
123
covering the optical fibres probe added to this problem. However, if large changes in 
posture were predicted then the optical fibres were lifted into a new position. 
Occasionally it was not possible to maintain adequate suction to the fetal head and the 
studies were abandoned. A leak was found in the suction tubing of the probe caused by 
blockage at the probe end from tissue. Therefore care was taken to avoid further 
blockage of the suction tubing in future studies.
The best way of ensuring stable measurements was by correct initial probe placement. 
The optimum position appeared to be when the probe was introduced posteriorly, as the 
suction cup was compressed against the curve of the sacrum by the fetal head, forced 
down by gravity and uterine contractions. In addition, the fibreoptic bundles were 
supported by the posterior vaginal wall. Low cervical dilatations in particular limited 
the positioning and application of the probe and if combined with a high presentation 
(i.e. unengaged head), then good apposition between the optodes and the fetal scalp was 
less likely to be achieved.
7.1.2 Contribution of superficial tissue
One of the main concerns with the use of infrared light to investigate blood volume and 
oxygenation in biological tissue is the contribution of skin and bone to the light signals. 
Table 7.1 summarises the physical changes that may occur and have a potential effect 
on intensity modulated light wave if used to investigate changes in biological tissue 
such as the fetal brain.
Table 7.1 Possible effects on IMOS data during physiological changes in biological 
tissue
Physical change Attenuation change Pathlength change
Absorption of brain t t 4
Optode separation t t t
Absorption skin 4 4 small
CSF layer 4 small 4
124
Because NIR light is transmitted through these haemoglobin-bearing tissues, as well as 
brain, any change in their oxygenation or haemoglobin content could have an effect on 
measurements. Young et al (2000) found a substantial difference in NIR light intensity 
when between applying a probe to the skin over adult brains compared with a probe 
applied to the cerebral cortex. However in the fetal and neonatal head this difference is 
likely to be small (<10%) because the superficial tissues are relatively thin (Wyatt 
1990). The size of the effect will depend partly on the distance between the transmit and 
receive optodes, so that at small interoptode spacings more of the signal will be derived 
from the scalp and skull, (Grubhofer 1997, Owen-Reece 1996). It is thought that the 
critical minimum interoptode spacing is probably 2.5 cms (van der Zee 1992). The light 
transmitted from the fibreoptic bundle is multiply scattered within the cranial 
compartment and the exact volume of brain tissue interrogated is not yet determined. 
The mean distance travelled by each photon is known to be 12-15cms and it is therefore 
probable that a signal is obtained from a substantial proportion of the brain. It is for this 
reason that exact positioning of the probe on the fetal scalp is unlikely to be important
Caput
It is also possible that caput formation during labour, leading to an increase in the 
extracellular fluid of the fetal scalp is another potential source of error. Lower values 
for fetal scalp saturation, measured by pulse oximetry, have been obtained from caput 
than from surrounding areas (Johnson 1990). The reason for this discrepancy is thought 
to be because haemoglobin saturation is genuinely lower over caput and also because 
oedema acts as a preferential absorber of red light, as opposed to near infrared light 
which has the effect of lowering the measured value for saturation. The effect of caput 
on near infrared observations remains difficult to determine accurately, although the 
fact that caput contains mostly serum rather than haemoglobin means that it is probably 
relatively transparent to NIR light. In practice caput did not seem to significantly alter 
either the quality or the magnitude of the signal, as similar data were obtained from one 
fetus when the probe was intermittently repositioned in different regions with and 
without obvious caput. The problem of caput during NIR monitoring may be avoided by 
routinely positioning the probe further back on the fetal scalp.
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Figure 7.1 Effect on the phase data when the fetal probe becomes dislodged from the 
fetal head.
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7.1.3 Signal quality
In some of the cases in which the probe was applied it was not possible to collect 
satisfactory data suitable for analysis. This was either due to poor signal quality that 
provided ‘noisy’ data but more commonly it was due to technical malfunctions within 
the spectrometer.
In eight of the cases poor quality signals provided data that was unsuitable for analysis. 
In six of these, there were identifiable contraction-related changes in the attenuation 
data but ‘noise’ dominated the signals in the phase and modulation depth data. An 
example of this is illustrated in figure 7.2 and the calculations of absolute 
concentrations are by the analytic programme are shown in table 7.2. As there is no 
correlation between the phase and modulation depth data in response to uterine 
contractions, the Mathematica programme would be unable to calculate ‘sensible’ 
absolute concentrations of Hb and HbC>2 .
It was not possible to detect noisy phase and modulation data during a study as the 
spectrometer only displayed changes in light intensity, which is related to attenuation. 
Conversely, the on-line display of the conventional NIRS monitors can give an 
indication of noise within the signal.
Previous NIRS studies have shown that the commonest reason for failure to acquire data 
or noise was the inability to transmit sufficient light through the tissue (Peebles 1993). 
This was observed most frequently if there was a combination of thick black curly hair 
and dark skin, as melanin significantly increases the attenuation of near infrared light. 
Although there were few African and Asians in this study, noisy phase and modulation 
depth data was still encountered despite being able to adjust the PMT sensitivity 
manually
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The reason behind this may be because the three signals (attenuation, phase and 
modulation) have different sensitivities to spatial variations. Arridge (1995) has 
demonstrated that attenuation data are especially sensitive to changes in absorption 
close to the surface of a medium, whereas phase and modulation are more sensitive to 
deeper tissue layers. Although NIR light travels through the brain to a depth of several 
centimetres, changes in blood volume or oxygenation in a blood vessel close to the 
surface could theoretically induce large attenuation changes while phase and modulation 
depth remain largely unaffected.
Table 7.1 Calculations of SmC02 and haemoglobin concentrations by the Mathematica 
programme when the data is dominated by noise.
Laser
combination
SmC02 HbT Hb Hb02
"{1,2}" -1.99875 8470.6 25401.2 -16930.6
"{1,3}" -0.101894 4.45983 4.91426 -0.454432
"{1,4}" 0 0 0 0
"{2,3}" 5.18735 2250.92 -9425.39 11676.3
"{2,4}" 0 0 0 0
"{3,4}" 0 0 0 0
"{1,2,3}" 1.26084 1183.31 -308.651 1491.96
"{1,2,4}" 0 0 0 0
"{1,3,4}" 0 0 0 0
"{2,3,4}" 0 0 0 0
"{1,2, 3,4}" 0 0 0 0
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Figure 7.2. Data collected from a fetus using IMOS in which the phase and modulation 
depth data is dominated by ‘noise’.
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7.1.4 Technical problems
The spectrometer and the fetal probe used in this thesis were prototypes, and so 
developmental problems were encountered. Despite satisfactory application of the fetal 
probe to the fetal head, it was not possible to collect data in eleven of the twenty-nine 
fetuses in which the probe was applied. In the first three intrapartum studies this was 
due to a problem with the timing mechanism of the spectrometer. In three further 
studies in which data was unobtainable the spectrometer failing to generate a light 
source. In 5 cases the PMT failed.
Unfortunately these technical malfunctions were not resolvable at the time of the studies 
and so the studies were abandoned. It was thought that these fragile components were 
damaged during transportation of the spectrometer from the Medical Physics 
Department to the delivery suite. Further proposed studies were also abandoned until 
any new components that were required were fitted and tested on optical phantoms 
within the Medical Physics department. To avoid further damage of the components of 
the spectrometer, it was kept on the delivery suite as much as possible.
Other minor practical problems with the spectrometer were encountered during it’s time 
on delivery suite. During the initial studies, the acoustic noise of the fan system of the 
spectrometer, which kept the lasers at a constant temperature, was too much for four 
women who declined to be monitored after having consented. Removing one of the fans 
for future studies reduced this acoustic noise.
The fetal studies required both JC and DK to be present for manoeuvring the 
spectrometer close to an electrical socket and a wall suction apparatus and also required 
DK to be present to provide technical assistance. The dimensions of the spectrometer 
are approximately twice that of a CTG monitor and of the conventional NIRS 
spectrometer and because of the large area taken up by the JC, DK and the 
spectrometer, three women declined to be part of the study after giving consent. All of 
the women, who were entered into the study, their partners and the midwifery and 
medical staff involved in their care, commented on the size of the spectrometer.
Currently the monitor of the spectrometer has the capability of displaying the number of 
photons back-scattered to the PMT for the four laser wavelengths. Changes in this
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number reflects the changes in light absorption during a study. However, it is only after 
a study is completed and data are passed through the analytic programme that changes 
in phase and modulation depth can be displayed. Furthermore, the spectrometer records 
data from the start of a study but it does not have the capability of displaying the 
number of photons in real-time. Additionally, the spectrometer does not have the 
facility of marking events that occur during data collection. These problems were 
overcome by strict recording of events both by JC and DK during the studies.
Faults in the design and manufacture of the first fetal probe that was made available 
were encountered before intrapartum studies were commenced. The optodes of this 
probe were manufactured in such a position within the silicone rubber moulding that the 
receiving optode collected all the light that was transmitted from the emitting optode. 
Thus its use for fetal studies was not appropriate. The second probe optodes were in a 
more satisfactory position (see figure 4.1) however the covering of the optical fibres 
was transparent to background light. A further heat-shrink covering was therefore 
required. As previously discussed, this covering made the probe less flexible and 
heavier and therefore during fetal studies the optical fibres were attached to the 
woman’s thigh to avoid displacement of the probe during a maternal movement. Lastly, 
the optical fibres are extremely fragile and therefore extreme care with the probe was 
necessary to ensure these fibres were not broken during intrapartum studies.
7.1.5 Analytic method
IMOS measurements of absolute haemoglobin concentration rely on changes in the 
three measured signals (attenuation, phase and modulation depth). However Arridge 
(1995) has shown that these three signals have different sensitivities to spatial variations 
in the absorption properties of media. He demonstrated that attenuation data are 
especially sensitive to changes in absorption near the light source or the detector i.e. 
close to the surface of the medium, whereas phase and modulation depth are more 
susceptible to changes in deeper tissue layers. These spatial sensitivity differences are of 
no consequence in homogenous media in which A/P and P/M can derive the same 
measurements of absorption characteristics. However, in inhomogeneous media, such as
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biological tissue the differences may be substantial. For example, any change in blood 
volume or oxygenation in a blood vessel close to the surface may induce large changes 
in attenuation while the other two signals remain largely unaffected. Consequently, in 
highly inhomogeneous media, it might be advantageous to base absolute concentrations 
on phase and modulation depth. Furthermore the deeper penetration depth of phase and 
modulation depth might be required for reducing artefact arising from the skin and 
skull. In practice however it was clear from the data in this thesis that the modulation 
depth data on the current spectrometer had a low signal/noise ratio throughout the fetal 
studies and consequently its use was limited in the absolute measurement of 
haemoglobin concentrations.
Finally, the analytic process of the raw data with the Mathematica programme is 
currently not incorporated into the software of the spectrometer. This is because 
analysis with the Mathematica programme requires an observer to select two data points 
to calculate the absolute Hb and HbC>2 concentrations. The process of computing the 
measurements from the raw data is time-consuming. For a single set of observations 
approximately 30 minutes are required. This length of time would therefore be 
impractical even if the analytic programme was incorporated within the spectrometer.
7.2 FUTURE DEVELOPMENTS
It is clear that technical developments are required. However, design and manufacture 
of the fetal probe for intrapartum infrared monitoring remains time-consuming and 
expensive. However, in the short term increasing the size of the fibreoptic bundles and 
prisms, particularly the receiving bundle and/or converting the prism holder into a 
similar sensor to a pulse oximetry may improve the performance. Unfortunately, 
because the probe has to create a vacuum, the fibreoptic bundles, which are currently 
very expensive (approximately £500 a pair) and not particularly robust, have to be 
sealed in place and handled very carefully.
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Because of the risk of infection and difficulties in cleaning, the probe would ideally be 
disposable. A smaller probe would also be beneficial for studying fetuses at lower 
cervical dilatations, however at the present time; this is not practical, as a minimum 
interoptode spacing of about 3cm is required. The probe moulding also has to support 
the optodes and allow a vacuum to form, which require it to be at least 1.5 cm wide. 
Making the probe moulding flatter and thinner similar to pulse oximetry sensors may be 
beneficial. In future a fetal probe for IMOS use would have to be robust enough to 
avoid damage to the prisms and the optical fibres, but at the same time be lightweight 
and flexible for intrapartum fetal monitoring.
Data interpretation remains complex and time-consuming. Attending medical and 
midwifery staff require measurements displayed online and in real time and require a 
system that would reject poor quality signals and artefact. Encouragingly, work is 
already underway at UCL to provide a smaller version of IMOS that is more user- 
friendly and more acceptable in the clinical setting. This may prove more acceptable to 
midwives and labouring women. This will incorporate the analytic programme in the 
hope that it would provide an on-screen display of fetal cerebral oxygenation 
parameters. This should lead to a large improvement in the usefulness of IMOS as a 
clinical tool. This would also provide online absolute pathlength measurement, which 
would be useful in determining the magnitude of changes in interoptode spacing 
induced by alterations in uterine contraction pressure.
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CHAPTER 8
CONCLUSION
In the conclusion to chapter 1, the requirements for the ideal method of intrapartum fetal 
surveillance were defined. It is now possible to compare IMOS in practice with this 
theoretical ideal technique.
1) The technique of IMOS allows the measurement of absolute fetal cerebral blood 
volume and saturation, rather than the peripheral saturation. These measurements are 
derived form absolute fetal cerebral oxyhaemoglobin and deoxyhaemoglobin. This is in 
contrast to conventional NIRS and pulse oximetry. Conventional NIRS measures 
changes in cerebral blood volume and therefore it’s clinical usefulness is limited.
2) IMOS provides information on fetal cerebral saturation and blood volume. Cerebral 
blood volume reflects cerebral perfusion which is known to be a crucial factor in the 
maintenance of cerebral function.
3) The raw data can be collected continuously, to provide measurements of cerebral 
blood volume from the early stages of labour, during FHR changes and up to and during 
delivery. It therefore has the potential to detect the already compromised fetus (e.g. 
IUGR) entering labour from knowledge of the cerebral haemodynamics.
4) The technique appears to be safe for both the fetus and mother and does not require 
the use of a scalp clip or other invasive means of fetal attachment. The probe is simple 
to insert, once the amniotic membranes are ruptured. Although this technique is "non- 
invasive", it does require a vaginal examination, and it also limits the woman’s freedom 
of movement. This may prove to be unacceptable for some women, especially those 
with fetuses at "low risk" of intrapartum hypoxic-ischaemic encephalopathy. However,
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it’s use was acceptable to the majority of mothers and causes minimal interference with 
routine midwifery and medical care on the labour ward. With the current spectrometer, 
the raw data can be collected during labour in approximately two-thirds of women who 
are selected for study. Of these, two thirds of fetuses provide data that is suitable for 
analysis. Furthermore, potential movement of the probe during uterine contractions 
appears to have little effect on these measurements.
5) The current available IMOS system however is expensive and it’s use is not straight 
forward. The significant number of failed studies due to technical problems led to a 
small number of fetuses studied. If more fetuses had been studied then it is probable that 
measurements could have been obtained from hypoxic fetuses. This would have 
provided further information on the complexities of changes in cerebral blood volume 
and saturation in response to acute and chronic insults to the fetus.
The future clinical role of fetal IMOS remains open to speculation. Further intrapartum 
studies are unlikely to take place with the current available tools for intensity modulated 
optical spectrometry. Technical refinements and validatory studies are required before 
future intrapartum trials are considered. In the first instance, the reliability, accuracy and 
reproducibility of the performance of the individual components of the spectrometer 
will need to be assessed further by laboratory based studies. Clinical studies using 
neonates and fetal sheep to compare established methods of measurement of cerebral 
blood volume and saturation with IMOS measurements will then be required. In line 
with this, the software controlling the data collection needs to be overhauled to provide 
on-line analysis in real time to provide a more user-friendly system.
It is only after these studies and improvements could IMOS be considered for 
intrapartum use to define normal ranges further, for the variables described, from a large 
number of uncomplicated deliveries. These data can then be compared with 
measurements obtained from fetuses thought to be at high risk of hypoxia-ischaemia, 
and those with evidence of "fetal distress" during labour. Deviations from "normal" in 
fetuses, which subsequently develop hypoxic-ischaemic brain injury, may suggest 
mechanisms by which such injury can occur.
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The establishment of normal values and physiological responses will enable 
abnormalities of cerebral oxygenation and haemodynamics occurring intrapartum to be 
correlated with neonatal outcome. This would be in the context of a large prospective 
study with long-term follow up and this would potentially provide a ‘cut-off 
measurements of cerebral blood volume and saturation below which neurological 
damage occurs and delivery would be recommended. After this, clinical intervention 
studies can be performed to ascertain whether knowledge of fetal cerebral circulation 
and haemodynamics can reduce the number of infants suffering hypoxic ischaemic 
brain injury. Only after such studies have been completed could the use of IMOS in 
clinical practice be contemplated.
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APPENDICES
Appendix 1. 
Derivation of absolute Hb and HbC>2 by the Mathematica based on diffusion 
theory
Diffusion theory has become established as a versatile tool for describing light intensity, 
time of flight (phase), and modulation depth in terms of the transport scattering 
coefficient (ps’X the absorption coefficient (pa), and the refractive index of a medium 
(n). Appendix 1 details the specific equations and theory that is required to derive 
absolute Hb and HbCh in biological tissue using diffusion theory.
For a pencil-beam light source on a semi-infinite half-space, the reflectance R (i.e., the 
number of photons back-scattered to the surface to the medium per unit area) and the 
mean transit time (time of flight) <t> detected at a distance r from the source can be 
written as
R(r) = Zo(l/p +  peff).exp(-peffp)/27ip2 (1)
<t>(r) = p2 /2c[D + p.(paD),/2] (2)
where p = (r2 + Zq2) /2, Zq = 1/ps’. c is the velocity of light in the medium, Peff = 
effective attenuation coefficient = [3pa(pa + Ps’) ] /2 and D is the diffusion coefficient = 
PGi. + ps’)]-1
Analytical expressions for the phase O and the modulation depth M have been derived 
by Patterson et al, such that
<D = y r - ta n ,[ 'tV (l+ 4 'i)]> (3)
M = [(1 + + 2vKj) v‘) / (1 + T„)].exp(v „ - v|/i),(4)
Where >|/o = Hefrp(l + %2)v‘ , y r = -y 0sin(e/2), H', = tFocos(0/2), 6  = tan‘'(x).
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and H'oo = jaefrp and x = (27ivM)/(PaC).
The derivative of attenuation A and <t> with respect to changes in pa can be derived for 
Eqns (1) and (2) giving
0A/0pa = [ 3.p.(2pa + Ps’) ]/[ (21).(l/p + Peff) ] (5)
3<t>/3|!a = - 3/2.[ [ (p/2 ).Us’ / V(hJ5) ] -  1 ] / [ ( 1 /p + mfr) 2 c ] (6 )
From these two quantities the quotient Q = (0A/dpa) / (0<t>/0pa) can be derived.
This ratio can be simplified by the use of the diffusion approximation, which states that 
scattering dominates absorption (pa«  Ps’), and therefore peff ~ V(3paps’) and D » 
Pps’)"1. Using these approximations, the ratio of equations (5) and (6 ) becomes:
(0A/dpa) / ( 0<t>/0pa) = Pa( -(1 + PPeff)c / [ (pp^ff/2) -  (pa/ps’) ] ) (7)
For media with optical properties similar to tissue, ( ps’ = 1-2 mm' 1 ; pa = 0.005 -  0.05 
mm'1) and typical source detector distances ( r = 20 -  40 m m), ppeff/2 »  pa/ps’ , and 
therefore:
(0A/0pa) / ( 0<t>/0pa) = pa(-2(l/peff + p)c / p) (8 )
For large source-detector distances, (p »  l/petr ), equation (8 ) is to a good 
approximation, independent of both p^’ and p. Equation (8 ) can therefore be reduced to:
(0A/0pa) /( 0<t>/0pa) = Pa (-2c/ln 10) (9)
which is a linear function of pa (and hence concentration) only.
Hence it is the ratio of the attenuation and phase shift that can be used to derive absolute 
pa which is independent of scattering and is relatively insensitive to uncertainties in the 
source-detector distance of 5mm. Similarly, two further ratios (V and R ) can be
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derived, where V = (dO/0pa) / (dM/dpa-M'1) and R = (dAJd\ia) / (0M/dpa. M*1) which 
are both linear functions of pa-
From these measured absolute absorption coefficient (pa), concentrations of Hb and 
HbC>2 can be derived as the extinction coefficients of the chromophores for the laser 
wavelengths are known:
Ha* = £1lb02, tH b02] + EHb'tHb] (10)
where pa is the absorption coefficient at wavelength of NIR light X, and 6 nb0 2  and Cub
are the extinction coefficients at wavelength X for HbC>2 and Hb respectively. Hence, if
two or more wavelengths (Xi and X2 ) are used, absolute concentrations of [HbC^] and
[Hb] ( in millimolar units) can be derived by solving two simultaneous equations as
follows:
[HbC>2] = (Pa^EHb*2  - Pa^EHb 1^)/(£HbX2 £Hb0 2 X1 - SHK^SHb*'1) (11)
[Hb] = (pa^ 2£Hb0 2 ^ 1 - PaX'1£Hb0 2 X2)/ (£HbX2£Hb0 2 A'1 - £Hb0 2 A'2£HbX1) (12)
From these absolute concentrations of HbC>2 and Hb, HbT and Smc0 2  can be derived :
Smc02 = 100% * [Hb02] / [Hb02] + [Hb] (13)
HbT = [Hb02] + [Hb] (14)
A measurement of Cerebral Blood Volume (mls/lOOg) (Elwell 1995) can be derived 
using the following equation:
CBV = HbT x MWHbxl0‘6/ tHb x 10‘2 x Dt x 10 
where MWnb is the molecular weight of haemoglobin (64500), tHb is the mean 
umbilical vein Hb concentration (16.8g/dl) (Wintrobe 1997) and Dt is the brain tissue 
density (1.05g/ml).
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Appendix 2.
Calculation of the true absorption coefficient of the ProJet dye used in the 
phantom experiment in chapter 3.
For the solution in the beaker, there are 495ml, of which 99% is water and 1% 
intralipid.
There is 300pi of dye (0.3ml) already in the phantom before dye is set to continuously 
infuse into the phantom at 2.5ml/hour. Hence total initial volume is 495.30ml.
At 140s after the start of the experiment, dye is being delivered to the phantom at a rate 
of 2.5ml/hour.
The total volume of the phantom for a time t beyond 2 V3 minutes (i.e. beyond 140 
seconds) is:
E Volume = 495.3 + [(2.5/60)*(t-2'/3)]
Hence the absorption coefficient of the phantom for a wavelength X, and for a time t is 
given by:
(phantom) = p /  (water) + [ [(0.3) + (2.5/60)*(t-2‘/3)] / [495.3 + (2.5/60)*( t-2'/3)]
]* (dye)
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Appendix 3
Information sheet for patients;
STUDIES OF THE OXYGEN SUPPLY TO THE BABY’S BRAIN DURING 
LABOUR
For the past seven years here at UCH we have been using a new kind off scanning 
technique, called near infrared spectroscopy, to see if we can measure the amount of 
oxygen getting to the brain of newborn babies. The technique is absolutely safe and 
does not upset the baby in any way. It has taught us a lot about the normal supply of 
oxygen and what can go wrong in ill babies.
We have now reached a stage where we believe we can measure the oxygen supply to 
the babies’ brain during labour and birth. This means that we may learn how to spot 
babies who are at risk of getting short of oxygen. Although we do not expect you to be 
in a high risk group, this may be of benefit to your baby.
After the waters have broken, a very thin rubber device is gently placed beside the 
baby's head and invisible infrared light shone into the head. The strength of the light 
beam is about the same as an ordinary battery torch bulb and there is no possibility of 
any harm. As soon as the baby is bom the device is taken off.
When you are admitted to the labour ward a research doctor may ask you if you would 
agree to have this scan on your baby. If you refuse, your decision will have absolutely 
no effect on the normal medical care you and your baby will receive. If you agree to 
have a scan please inform your midwife.
Thank you for taking time to read this.
I agree to the study of my baby as described above and explained to me by 
Dr J Chipchase.
Signed ..............................
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